<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2024.1393111</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Research progress on the fanconi anemia signaling pathway in non-obstructive azoospermia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Xu</surname><given-names>Haohui</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zhang</surname><given-names>Yixin</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1962881"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wang</surname><given-names>Caiqin</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2367084"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fu</surname><given-names>Zhuoyan</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lv</surname><given-names>Jing</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname><given-names>Yufang</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname><given-names>Zihan</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qi</surname><given-names>Yuanmin</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Meng</surname><given-names>Kai</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1910774"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yuan</surname><given-names>Jinxiang</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1296415"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname><given-names>Xiaomei</given-names>
</name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1406926"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Lin He&#x2019;s Academician Workstation of New Medicine and Clinical Translation, Jining Medical University</institution>, <addr-line>Jining</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>College of Second Clinical Medical, Jining Medical University</institution>, <addr-line>Jining</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>College of Clinical Medicine, Jining Medical University</institution>, <addr-line>Jining</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>College of Mental Health, Jining Medical University</institution>, <addr-line>Jining</addr-line>, <country>China</country></aff>
<aff id="aff5"><sup>5</sup><institution>College of Basic Medicine, Jining Medical University</institution>, <addr-line>Jining</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Marjan Sabbaghian, Royan Institute, Iran</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Panneerselvam Jayabal, The University of Texas Health Science Center at San Antonio, United States</p>
<p>Hongzheng Sun, Nanjing Medical University, China</p>
<p>Fenglei Chen, Yangzhou University, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Kai Meng, <email xlink:href="mailto:mengkai521888@126.com">mengkai521888@126.com</email>; Jinxiang Yuan, <email xlink:href="mailto:yuanjinxiang18@163.com">yuanjinxiang18@163.com</email>; Xiaomei Wang, <email xlink:href="mailto:xichebingqing@163.com">xichebingqing@163.com</email>
</p>
</fn>
<fn fn-type="equal" id="fn002">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>05</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1393111</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>02</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>05</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Xu, Zhang, Wang, Fu, Lv, Yang, Zhang, Qi, Meng, Yuan and Wang</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Xu, Zhang, Wang, Fu, Lv, Yang, Zhang, Qi, Meng, Yuan and Wang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Non-obstructive azoospermia (NOA) is a disease characterized by spermatogenesis failure and comprises phenotypes such as hypospermatogenesis, mature arrest, and Sertoli cell-only syndrome. Studies have shown that FA cross-linked anemia (FA) pathway is closely related to the occurrence of NOA. There are FA gene mutations in male NOA patients, which cause significant damage to male germ cells. The FA pathway is activated in the presence of DNA interstrand cross-links; the key step in activating this pathway is the mono-ubiquitination of the FANCD2-FANCI complex, and the activation of the FA pathway can repair DNA damage such as DNA double-strand breaks. Therefore, we believe that the FA pathway affects germ cells during DNA damage repair, resulting in minimal or even disappearance of mature sperm in males. This review summarizes the regulatory mechanisms of FA-related genes in male azoospermia, with the aim of providing a theoretical reference for clinical research and exploration of related genes.</p>
</abstract>
<kwd-group>
<kwd>non-obstructive azoospermia</kwd>
<kwd>Fanconi anemia pathway</kwd>
<kwd>Fanconi anemia gene</kwd>
<kwd>interstrand crosslinks</kwd>
<kwd>homologous recombination</kwd>
</kwd-group>
<counts>
<fig-count count="2"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="191"/>
<page-count count="16"/>
<word-count count="7894"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Reproduction</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Male infertility is a common reproductive disease that affects multiple families eager to create a new life. Existing research statistics have found that approximately seven out of every 100 males suffer from infertility symptoms (<xref ref-type="bibr" rid="B1">1</xref>). Of these, 13-17% of infertile men are due to azoospermia, which accounts for 55-65% of non-obstructive azoospermia (<xref ref-type="bibr" rid="B2">2</xref>). It is generally believed that the main cause of male infertility may be abnormal reduction in sperm count or even azoospermia caused by factors such as congenital inheritance or acquired living environment (<xref ref-type="bibr" rid="B3">3</xref>). Azoospermia is an extreme form of decreased sperm count during ejaculation, divided into two types: obstructive azoospermia (OA) and non-obstructive azoospermia (NOA) (<xref ref-type="bibr" rid="B4">4</xref>). The viability of sperm is closely related to the health status of the testes, and NOA is the result of abnormal gene expression in the testes. The entire ejaculatory duct of NOA is open and functioning normally, but the number of healthy sperm is very low, which may be related to genetic mutations (<xref ref-type="bibr" rid="B5">5</xref>). Interstrand cross-linking (ICL) has a direct effect on the proliferation of male germ cells and sperm maturation, and the error repair of ICL will lead to the production of NOA (<xref ref-type="bibr" rid="B6">6</xref>). Fanconi anemia (FA) is a chromosomally inherited disease caused by mutations in the FA genes. It affects the same signaling pathway through multiple sets of genes and is highly sensitive to damage of intracellular genetic material (<xref ref-type="bibr" rid="B7">7</xref>). Studies have found that the deletion of FA gene is closely related to reproductive diseases, especially interference with primordial germ cells (PGCs), including ovarian and breast cancer in women and azoospermia in men (<xref ref-type="bibr" rid="B8">8</xref>&#x2013;<xref ref-type="bibr" rid="B10">10</xref>). Some of the genes in the FA pathway are important for the repair process of ICL of DNA (<xref ref-type="bibr" rid="B11">11</xref>). In this review, we focus on exploring the relationship between FA genes and male azoospermia. For example, Krausz et&#xa0;al. (<xref ref-type="bibr" rid="B12">12</xref>)reported a high correlation between NOA and the pathogenic variation of the Fanconi gene in the FA pathway; Tsui et&#xa0;al. (<xref ref-type="bibr" rid="B13">13</xref>)also suspected that homozygous mutations in <italic>FANCM</italic> can lead to the occurrence of NOA. The association between the Fanconi gene and male NOA deserves further research, such as whether abnormal DNA damage and calcium signaling abnormalities in FA have an impact on sperm formation and maturation (<xref ref-type="bibr" rid="B14">14</xref>). Based on the relevant research results in recent years, this review summarizes the molecular-level interaction mechanism and relationship between the specific genes of FA and NOA, aiming to provide helpful insights for the treatment of azoospermia and research on FA from a genetic perspective.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>The mechanism of fanconi anemia</title>
<p>The FA pathway is associated with genetic disorders that primarily play a role in DNA replication (<xref ref-type="bibr" rid="B11">11</xref>). DNA replication includes processes such as unwinding, catalysis by DNA polymerase, and DNA ligase connecting Okazaki fragments, and replication is carried out in a semiconservative replication manner (<xref ref-type="bibr" rid="B15">15</xref>). This process requires the collaboration of multiple enzymes and is prone to errors. Damaged DNA needs to be repaired or cleared in a timely manner, and FA signals are involved in this process (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). There are currently 22 known genes related to the FA pathway (<xref ref-type="bibr" rid="B16">16</xref>): <italic>FANCA (</italic>
<xref ref-type="bibr" rid="B17">17</xref>), <italic>FANCB (</italic>
<xref ref-type="bibr" rid="B18">18</xref>), <italic>FANCC (</italic>
<xref ref-type="bibr" rid="B19">19</xref>), <italic>FANCD1</italic> (<italic>BRCA2</italic>) (<xref ref-type="bibr" rid="B20">20</xref>), <italic>FANCD2 (</italic>
<xref ref-type="bibr" rid="B21">21</xref>), <italic>FANCE (</italic>
<xref ref-type="bibr" rid="B22">22</xref>), <italic>FANCF (</italic>
<xref ref-type="bibr" rid="B21">21</xref>), <italic>FANCG</italic> (<italic>XRCC9</italic>) (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B23">23</xref>), <italic>FANCI (</italic>
<xref ref-type="bibr" rid="B21">21</xref>), <italic>FANCJ</italic> (<italic>BRIP1</italic>/<italic>BACH1</italic>) (<xref ref-type="bibr" rid="B24">24</xref>), <italic>FANCL (</italic>
<xref ref-type="bibr" rid="B25">25</xref>), <italic>FANCM (</italic>
<xref ref-type="bibr" rid="B26">26</xref>), <italic>FANCN</italic> (<italic>PALB2</italic>) (<xref ref-type="bibr" rid="B27">27</xref>), <italic>FANCO</italic> (<italic>RAD51C</italic>) (<xref ref-type="bibr" rid="B28">28</xref>), <italic>FANCP</italic> (<italic>SLX4</italic>) (<xref ref-type="bibr" rid="B29">29</xref>), <italic>FANCQ</italic> (<italic>ERCC4</italic>) (<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B31">31</xref>), <italic>FANCR</italic> (<italic>RAD51</italic>) (<xref ref-type="bibr" rid="B31">31</xref>), <italic>FANCS</italic> (<italic>BRCA1</italic>) (<xref ref-type="bibr" rid="B32">32</xref>), <italic>FANCT</italic> (<italic>UBE2T</italic>) (<xref ref-type="bibr" rid="B25">25</xref>), <italic>FANCU</italic> (<italic>XRCC2</italic>) (<xref ref-type="bibr" rid="B33">33</xref>), <italic>FANCV</italic> (<italic>REV7</italic>) (<xref ref-type="bibr" rid="B34">34</xref>) and <italic>FANCW (</italic>
<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>) (<xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>). Research has shown that the FA pathway can be classified upstream, middle, and downstream of FANCD2 ubiquitination: Upstream is mediated by a complex enzyme composed of FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCI, FANCL and FANCM (<xref ref-type="bibr" rid="B110">110</xref>). The ubiquitination of FANCD2 by these complex results from the activation of FANCT by FANCL, and FANCD2 often binds to FANCI, resulting in the ubiquitination of FANCD2-FANCI (ID2) complex (<xref ref-type="bibr" rid="B111">111</xref>&#x2013;<xref ref-type="bibr" rid="B113">113</xref>). The ubiquitination of the ID2 complex induces processes such as cleavage and homologous recombination of endonucleases, leading to de-ubiquitination and ultimately completing DNA damage repair (<xref ref-type="bibr" rid="B114">114</xref>, <xref ref-type="bibr" rid="B115">115</xref>) (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1</bold></xref>). In the FA pathway, signaling networks formed by protein complex enzymes such as FANCA can dynamically monitor the process of DNA changes (<xref ref-type="bibr" rid="B116">116</xref>). Damage or termination of DNA replication forks can activate upstream FA proteins, thereby regulating downstream genes such as <italic>FANCP</italic> to correct DNA damage and restore normal replication process (<xref ref-type="bibr" rid="B116">116</xref>). One of the most important links connecting the upstream and downstream FA signaling pathways is the ubiquitination of FANCI-FANCD2 (<xref ref-type="bibr" rid="B116">116</xref>). The FRT-flanked neomycin cassette can target the <italic>FANCG</italic> gene in mouse embryonic stem cells, causing the defect of this gene and further blocking the protein signal network that binds FANCG to the SH3 domain of RIISp, and the DNA repair of embryonic stem cells cannot be completed (<xref ref-type="bibr" rid="B117">117</xref>, <xref ref-type="bibr" rid="B118">118</xref>). Embryonic stem cells can differentiate into germ cells, so blocking the FNACG signaling pathway may reduce the number of sperm in mice (<xref ref-type="bibr" rid="B117">117</xref>&#x2013;<xref ref-type="bibr" rid="B119">119</xref>). In addition, exogenous stimuli such as cisplatin and mitomycin C lead to the production of cellular ICL, where the FA protein recognizes and repairs damaged DNA or excises faulty coding (<xref ref-type="bibr" rid="B120">120</xref>). When the FA gene is missing, the damaged DNA accumulates in the cell, The resulting self-nucleic acids activate the cyclic GMP-AMP synthase (cGAS) in the cytoplasm to produce secondary messenger cGAMP, which in turn activates type I interferons (IFN-I), which is involved in the emergence of Fanconi related disease phenotypes via the cGAS-STING-IFN-I axis (<xref ref-type="bibr" rid="B120">120</xref>, <xref ref-type="bibr" rid="B121">121</xref>). It can be seen that FA, as a signal pathway of target gene, is closely related to DNA damage repair. In addition, studies have shown that abnormal DNA repair can lead to the occurrence of NOA (<xref ref-type="bibr" rid="B6">6</xref>). Taking FA signaling pathway as the starting point, we will elaborate on the effects and possible roles of various FA genes in male NOA according to the upstream, middle, and downstream processes of FANCD2 ubiquitination (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2</bold></xref>).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>The position of human FA gene and its mechanism and influence on NOA.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Site of action</th>
<th valign="middle" align="left">Gene</th>
<th valign="middle" align="left">Another name</th>
<th valign="middle" align="left">Chromosomal location</th>
<th valign="middle" align="left">Mechanism</th>
<th valign="middle" align="left">Impact on NOA after mutation</th>
<th valign="middle" align="left">References</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" rowspan="9" align="left">Ubiquitination upstream</td>
<td valign="middle" align="left">FANCM</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left">14q21.2</td>
<td valign="middle" align="left">Regulation of the ubiquitination of FANCD2; S-phase identification ICL; Participation in the formation of replication forks; Repair of damaged DNA</td>
<td valign="middle" align="left">Copy fork stop; ICL repair failed; Sperm maturation arrest; dyszoospermia, Inability to conceive</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B37">37</xref>&#x2013;<xref ref-type="bibr" rid="B42">42</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">FANCA</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left">16q24.3</td>
<td valign="middle" align="left">Accumulation of FANC ubiquitinase, Stable DNA replication; </td>
<td valign="middle" align="left">Apoptosis of PGCs and decrease in sperm count; Persistent double strand breaks in DNA</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B43">43</xref>&#x2013;<xref ref-type="bibr" rid="B45">45</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">FANCG</td>
<td valign="middle" align="left">XRCC9</td>
<td valign="middle" align="left">9p13.3</td>
<td valign="middle" align="left">Formation of a complex with FANCA to assist with FANCA protein</td>
<td valign="middle" align="left">Reduced number of germ cells; Persistent double strand breaks in DNA</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">FANCB</td>
<td valign="middle" align="left">FAAP95</td>
<td valign="middle" align="left">Xp22.2</td>
<td valign="middle" align="left">Enrichment and maintenance of spermatogonia; Repair of DNA damage</td>
<td valign="middle" align="left">Reduced PGCs and infertility; ICL repair failure, termination of HR and SCEs, meiosis failure</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B48">48</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">FANCC</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left">9q22.32</td>
<td valign="middle" align="left">Participation in the ubiquitination process, repair of DNA damage, and germ cell maintenance</td>
<td valign="middle" align="left">Interference with the mitotic process of germ cells</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">FANCE</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left">6p21.3</td>
<td valign="middle" align="left">In the S phase, FANCD2 can be ubiquitinated and participate in the assembly of FA complexes, as well as in the repair of ICL; Formation of FANCE/FANCC complexes to participate in the FA pathway</td>
<td valign="middle" align="left">Few germ cells; Low intracellular levels of FANCC, failed assembly of FA complexes, failed ubiquitination of FANCD2, failed ICL repair, blocked cell division cycle, increased cell mortality, difficulty in spermatogenesis</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B51">51</xref>&#x2013;<xref ref-type="bibr" rid="B57">57</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">FANCF</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left">11p15</td>
<td valign="middle" align="left">Protection of the genome; Maintenance of stability of FA core complex and promotion of ubiquitination of ID2 complex</td>
<td valign="middle" align="left">Increased COs levels; Gonad damage</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B58">58</xref>&#x2013;<xref ref-type="bibr" rid="B60">60</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">FANCL</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left">2p16.1</td>
<td valign="middle" align="left">Repair of damaged DNA; Regulation of ID2 complex, reduction of DNA strand cross-linking, inhibition of DNA fragment crossing, and stabilization of cellular genetics</td>
<td valign="middle" align="left">Massive apoptosis of germ cells, damage to sperm in the epididymis, and failure of normal differentiation of spermatogonia</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B61">61</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">FANCT</td>
<td valign="middle" align="left">UBE2T</td>
<td valign="middle" align="left">1q32.1</td>
<td valign="middle" align="left">Regulation of ID2 complex, reduction of DNA strand cross-linking, inhibition of DNA fragment crossing, and stabilization of cellular genetics</td>
<td valign="middle" align="left">DNA replication disorder, affecting germ cell mitosis</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B61">61</xref>, <xref ref-type="bibr" rid="B62">62</xref>)</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">Ubiquitin</td>
<td valign="middle" align="left">FANCD2</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left">3p25.3</td>
<td valign="middle" align="left">Participate in repairing damaged DNA; Initiation of processes such as nucleotide excision and homologous recombination; Reactivation of cell cycle</td>
<td valign="middle" align="left">The genetics of germ cells are prone to damage during division, resulting in minimal sperm count</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B63">63</xref>&#x2013;<xref ref-type="bibr" rid="B65">65</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">FANCI</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left">15q26.1</td>
<td valign="middle" align="left">Participation in repairing damaged DNA; Initiation of processes such as nucleotide excision and homologous recombination to reactivate the cell cycle</td>
<td valign="middle" align="left">Reduced number of spermatocytes</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B64">64</xref>, <xref ref-type="bibr" rid="B66">66</xref>)</td>
</tr>
<tr>
<td valign="middle" rowspan="11" align="left">Ubiquitination downstream</td>
<td valign="middle" align="left">FANCP</td>
<td valign="middle" align="left">SLX4</td>
<td valign="middle" align="left">16p13.3</td>
<td valign="middle" align="left">Maintenance of gene stability; Repair and inhibition of DNA ICL; Inhibition of intermediates produced by homologous recombination</td>
<td valign="middle" align="left">Increased COs levels</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B67">67</xref>, <xref ref-type="bibr" rid="B68">68</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">FANCQ</td>
<td valign="middle" align="left">ERCC4</td>
<td valign="middle" align="left">16p13.12</td>
<td valign="middle" align="left">XPF/ERCC1 directly acts on the ICL repair site; XPF participates in nucleotide excision repair and indirectly participates in ICL repair; Ensures the correctness of chromosome separation</td>
<td valign="middle" align="left">ICL repair defects, Meiotic recombination error, Sperm cell cycle arrest</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B69">69</xref>&#x2013;<xref ref-type="bibr" rid="B74">74</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">FANCV</td>
<td valign="middle" align="left">REV7/MAD2L2</td>
<td valign="middle" align="left">1p36.22</td>
<td valign="middle" align="left">Formation of DNA polymerase subunits, Participation in repairing damaged DNA</td>
<td valign="middle" align="left">Reduced number of PGCs; Apoptosis of primitive germ cells and underdeveloped testicular germ cells, Cell cycle arrest, chromosome breakage, Difficulty in cell proliferation and spermatogenic defects</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B75">75</xref>&#x2013;<xref ref-type="bibr" rid="B80">80</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">FANCN</td>
<td valign="middle" align="left">PALB2</td>
<td valign="middle" align="left">16p12.12</td>
<td valign="middle" align="left">Participation in homologous recombination repair; Combination of FANCS and recruitment of FANCD1 and FANCR</td>
<td valign="middle" align="left">Chromosome recombination obstruction, cell cycle arrest, Germ cell apoptosis</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B81">81</xref>&#x2013;<xref ref-type="bibr" rid="B85">85</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">FANCS</td>
<td valign="middle" align="left">BRCA1</td>
<td valign="middle" align="left">17q21.31</td>
<td valign="middle" align="left">Participation in DNA damage repair, maintenance of genome integrity and stability</td>
<td valign="middle" align="left">Reduced gene expression related to repairing DNA damage, Inability to repair damaged spermatocytes in a timely manner, reduced testicular volume and inability of the seminiferous tubules to produce sperm</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B86">86</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">FANCD1</td>
<td valign="middle" align="left">BRCA2</td>
<td valign="middle" align="left">13q12.3</td>
<td valign="middle" align="left">Participation in DNA repair through the FA pathway and in homologous recombination repair process through ID2 ubiquitination; Regulation of RAD51 protein participation in homologous recombination repair through binding to DNA</td>
<td valign="middle" align="left">ICL repair failure, meiosis stagnated at checkpoints; Abnormal spermatocyte-to-sperm process, Decrease in the proportion of sperm maturation, cell apoptosis, and male symptoms of oligospermia or azoospermia</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B87">87</xref>&#x2013;<xref ref-type="bibr" rid="B90">90</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">FANCO</td>
<td valign="middle" align="left">RAD51C</td>
<td valign="middle" align="left">17q22</td>
<td valign="middle" align="left">ICL repair; Protection of correct chromosome segregation during meiosis</td>
<td valign="middle" align="left">Enhanced sensitivity of DNA interstrand cross-linking; Suspended development of spermatocytes during the first division of meiosis</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B91">91</xref>&#x2013;<xref ref-type="bibr" rid="B94">94</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">FANCR</td>
<td valign="middle" align="left">RAD51</td>
<td valign="middle" align="left">15q15.1</td>
<td valign="middle" align="left">ICL repair; HR for regulation; Protection of correct chromosome segregation during meiosis</td>
<td valign="middle" align="left">Termination of meiosis leading to azoospermia; Chromosome division error causing crossover (CO) phenomenon, Inaccurate chromosome localization</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B91">91</xref>, <xref ref-type="bibr" rid="B92">92</xref>, <xref ref-type="bibr" rid="B95">95</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">FANCU</td>
<td valign="middle" align="left">XRCC2</td>
<td valign="middle" align="left">7q36.1</td>
<td valign="middle" align="left">Participation in restarting the replication process; Participation in the process of repairing double chain fractures</td>
<td valign="middle" align="left">Copy fork collapse, chromosome breakage, cell division termination; Homologous recombination repair defects, cell apoptosis</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B96">96</xref>&#x2013;<xref ref-type="bibr" rid="B99">99</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">FANCW</td>
<td valign="middle" align="left">RFWD3</td>
<td valign="middle" align="left">16q23.1</td>
<td valign="middle" align="left">Participation in homologous recombination and DNA repair process; Recruitment by RPA to a stagnant replication fork, participation in the ATR signaling pathway through phosphorylation of checkpoint kinase ATM/ATR, and control of DNA replication checkpoints to restart the replication fork</td>
<td valign="middle" align="left">Cell cycle arrest and apoptosis</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B87">87</xref>, <xref ref-type="bibr" rid="B100">100</xref>&#x2013;<xref ref-type="bibr" rid="B106">106</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">FANCJ</td>
<td valign="middle" align="left">BRIP1/BACH1</td>
<td valign="middle" align="left">17q22.2</td>
<td valign="middle" align="left">Participation in repairing ICL and DSB through HR; Regulation of replication forks reduces damage to chromatin structure during replication, ensuring normal chromatin replication while maintaining genetic stability</td>
<td valign="middle" align="left">Reduced resistance to ICL; Severe interference with spermatogenesis</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B107">107</xref>&#x2013;<xref ref-type="bibr" rid="B109">109</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>ICL, interstrand cross-linking; PGC, primordial germ cell; HR, primordial germ cell; SCE, sister chromosome exchange; CO, crossover; DSB, double-strand breaks.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>(By Figdraw) A model of the mechanism of action of FA genes. The FA gene action sites are divided into three parts: upper, middle, and lower. Proteins such as FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCI, FANCL and FANCM that exist upstream combine to form FA core complexes; ubiquitination of the ID2 complex located in the middle reaches is the main step in repairing DNA damage such as ICL, and the ID2 complex is the main pathway for activating downstream; the downstream protein SLX4 (FANCP) catalyzes ICL decoupling and binding to ERCC4 (FANCQ) through the UBZ-1 domain. REV7 (FANCV) and REV3 form a DNA polymerase complex for ICL repair. Under the action of FANCN, BRCA1 (FANCS) binds to BRCA2 (FANCD1) and acts together with RAD51 (FANCR) to repair DSB. RAD51C binds to XRCC3 to form a complex and is dependent on RAD51 to maintain normal division.However, XRCC2 (FANCU) forms a complex with RAD51 and has replication restart effect, which can repair homologous recombination. The C end of FANCW binds to PRA and is recruited by it to restart the replication fork. RAD51 (FANCR) can be used to repair DNA double-strand break. FANCJ repairs DNA interstrand cross-linking through homologous recombination (HR). (Note: The diagram is not the actual spatial configuration of the FA core complex, it is only a schematic diagram).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1393111-g001.tif"/>
</fig>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>(By Figdraw) Schematic diagram of the influence of FA gene on sperm development process. FA genes affect almost every stage from primitive germ cells to sperm development. Mutations in the <italic>FANCA</italic>, <italic>FANCB</italic>, <italic>FANCV and FANCJ</italic> gene can cause apoptosis in primordial germ cells. During the mitotic stage, <italic>FANCC</italic>, <italic>FANCT</italic>, <italic>FANCV</italic> and <italic>FANCL</italic> mutations prevent the formation of spermatogonia, and a group of genes also play an important role in the formation of primary spermatocytes. Most genes affect the meiotic stage, while <italic>FANCD1</italic>, <italic>FANCM</italic> and <italic>FANCW</italic> mutant spermatocytes cannot form mature sperm.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1393111-g002.tif"/>
</fig>
</sec>
<sec id="s3">
<label>3</label>
<title>The role of ICL in repairing defects leading to NOA occurrence</title>
<p>In physiological conditions, DNA replication is more common in poorly differentiated embryonic stem cells with the ability to divide (<xref ref-type="bibr" rid="B122">122</xref>). ICL is a type of DNA damage that poses great harm during DNA replication, known as the obstruction of replication forks, which has a significant effect on the development of germ cells (<xref ref-type="bibr" rid="B123">123</xref>). ICL can terminate normal DNA unwinding, causing replication and transcription abnormalities and leading to meiosis arrest, chromosome breakage, and abnormal chromosome binding, significantly damaging the cell&#x2019;s proliferative ability and causing abnormal germ cell development (<xref ref-type="bibr" rid="B124">124</xref>, <xref ref-type="bibr" rid="B125">125</xref>). Zhang et&#xa0;al. found that the Sertoli cell-only syndrome phenotype of NOA may be related to ICL repair defects and is associated with DNA replication in germ cells (<xref ref-type="bibr" rid="B126">126</xref>). In the upstream of the FA signaling pathway, mutations in the <italic>FANCM/A/G/B/C</italic> gene have been shown to be associated with human NOA (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B127">127</xref>). Among them, FANCM defect will cause the FA core complex enzyme in the cell to be unable to recognize ICL in time, and the deletion of FANCA/G/B/C gene will cause the FA core complex enzyme to be unable to associate with FANCD2 ubiquitination, resulting in abnormal repair of ICL (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B50">50</xref>). ICL persists and interferes with the normal replication of DNA, eventually leading to the proliferation of male germ cells and a decrease in male sperm count (<xref ref-type="bibr" rid="B124">124</xref>, <xref ref-type="bibr" rid="B125">125</xref>). The ubiquitination of FANCD2 is closely related to the repair of ICL, and <italic>FANCD2</italic> mutations occur at the K561 site in patients with FA. Due to genetic mutations, FANCD2 is unable to complete ubiquitination (<xref ref-type="bibr" rid="B51">51</xref>). Failure of the FANCD2 ubiquitination process causes cells to stall in the S phase (<xref ref-type="bibr" rid="B51">51</xref>), unable to produce mature sperm. At the same time, in the downstream of the FA pathway, homologous recombination mediated by FANCN/FANCU and other proteins is involved in the subsequent ICL repair process, and the defects of related genes lead to the reduction of sperm quantity and quality (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B95">95</xref>, <xref ref-type="bibr" rid="B96">96</xref>). The essence of NOA is the reduction of sperm count, which is often caused by the failure of migration of PGCs (<xref ref-type="bibr" rid="B128">128</xref>) and abnormal mitosis and meiosis of PGCs (<xref ref-type="bibr" rid="B8">8</xref>). For men, a defect in the repair of DNA cross-linking between strands during the formation of sperm can cause problems in the gene expression of PGCs, leading to defects in the sperm and even the inability to form mature sperm, leading to NOA or oligospermia (<xref ref-type="bibr" rid="B6">6</xref>). Therefore, the FA signaling pathway is related to the occurrence of NOA, and the defects of related genes will hinder the repair process of ICL and eventually lead to the occurrence of NOA.</p>
</sec>
<sec id="s4">
<label>4</label>
<title>FA gene leads to the occurrence of NOA</title>
<sec id="s4_1">
<label>4.1</label>
<title>The effect of ID2 ubiquitination upstream defects on NOA</title>
<sec id="s4_1_1">
<label>4.1.1</label>
<title><italic>FANCM</italic>
</title>
<p>The expression product of <italic>FANCM</italic> is a protein comprising the FA core complex. The FANCM protein has seven domains: aa 5-12, aa 77-590, aa 661-800, aa 826-967, aa 1218-1251, aa 1818-1956, and aa 1971-2030. Each domain is involved in different stages of FA and has genetic significance for the formation of NOA (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B129">129</xref>). According to reports, <italic>FANCM</italic> mutants are present in patients with NOA (<xref ref-type="bibr" rid="B129">129</xref>). Kherraf et&#xa0;al. analyzed 151 genes using whole-exome sequencing and found a homozygous mutation in the <italic>FANCM</italic> gene of patients with NOA (NM_020937.4: c.5791C&gt;T; p.Arg1931Ter) (<xref ref-type="bibr" rid="B127">127</xref>). Previous studies have shown that after truncated <italic>FANCM</italic> mutations, the major histone fold binding domain, MM1 (aa 826-967) domain, MM2 (aa 1218-1251) domain, and ERCC4 (aa 1818-1956) domain cannot express the corresponding proteins, leading to spermatogenesis disorders and infertility (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B39">39</xref>). Furthermore, FANCM can regulate the ubiquitination process of FANCD2 and play an important role in DNA repair. Studies have shown that mutations in the DEAH (aa 77-590), MM1 (aa 826-967), and FANCM-PIPbox (aa 5-12) domains of FANCM can lead to the inability to recruit FA complexes and FANCD2 to undergo ubiquitination, leading to the disruption of DNA repair processes (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B41">41</xref>), thereby blocking the proliferation of germ cells. Yin et&#xa0;al. found that adult mouse sperm inside the testicles with <italic>FANCM</italic> mutations were lost and sperm maturation was delayed (<xref ref-type="bibr" rid="B42">42</xref>), which may be related to DNA damage, such as FANCM binding to FAAP24 protein at the termination of a replication fork and recognition of ICL in the S phase (<xref ref-type="bibr" rid="B37">37</xref>). Therefore, during cell division, <italic>FANCM</italic> mutations may lead to the formation of FA complexes and the inability of FANCD2 to complete ubiquitination, resulting in the inability to repair ICL. Ultimately, the number of sperm in seminiferous tubules may decrease because of the inability of spermatogonia cells to proliferate and mature, leading to the occurrence of NOA.</p>
</sec>
<sec id="s4_1_2">
<label>4.1.2</label>
<title><italic>FANCA-FANCG</italic>
</title>
<p>The <italic>FANCA</italic> gene is currently one of the genes generating the most interest (<xref ref-type="bibr" rid="B43">43</xref>), along with <italic>FANCG</italic>, also known as <italic>XRCC9 (</italic>
<xref ref-type="bibr" rid="B23">23</xref>). <italic>FANCA</italic> is an important gene for repairing DNA breakage and is mainly expressed in the testes (<xref ref-type="bibr" rid="B130">130</xref>). The complex composed of two gene-encoded proteins is one of the main elements involved in the formation of ubiquitination complex enzymes (<xref ref-type="bibr" rid="B17">17</xref>). FANCA uses the amino terminal nuclear localization signal to bind to the FANCG protein to increase the content of the FANCA protein, leading to the accumulation of FANC ubiquitinase in the nucleus (<xref ref-type="bibr" rid="B44">44</xref>), which is conducive to stable DNA replication. In contrast, the FANCG protein can assist the FANCA protein in DNA repair (<xref ref-type="bibr" rid="B17">17</xref>). Krausz et&#xa0;al. found that pathogenic mutations in <italic>FANCA</italic> lead to NOA (<xref ref-type="bibr" rid="B12">12</xref>). They sequenced two types of patients and found that the first type had c.2639G&gt;A mutations, while the second type had two types of mutations, [NM_000135.2: c.3788-3790delTCT, p.Phe1263del] and [NM_000135.2: c.3913C&gt;T, p.Leu1305Phe], both of which had significant pathogenicity (<xref ref-type="bibr" rid="B12">12</xref>). Simultaneously, studies have found that <italic>FANCA</italic> mutated and showed high expression (<xref ref-type="bibr" rid="B12">12</xref>) after biopsy of tissues from patients with NOA (<xref ref-type="bibr" rid="B131">131</xref>). Furthermore, Wong et&#xa0;al. found that under the action of <italic>FANCA</italic><sup>tm1.1Hsc</sup> homozygotes, the number PGCs may decrease due to their inability to survive or divide (<xref ref-type="bibr" rid="B43">43</xref>). Simultaneously, the number of errors during meiosis in spermatocytes and apoptosis in spermatocytes increase, ultimately resulting in almost zero sperm count in the vas deferens (<xref ref-type="bibr" rid="B43">43</xref>). After mutation of the <italic>FANCG</italic> gene, PGCs are blocked during the S phase, resulting in a decrease in the number of PGCs and can interfere with the migration process of PGCs to the testes through Rac1 (<xref ref-type="bibr" rid="B46">46</xref>). After a <italic>FANCA</italic> or <italic>FANCG</italic> defect mutation, double stranded breaks in DNA become difficult to repair (<xref ref-type="bibr" rid="B45">45</xref>). The FANCA-FANCG complex can interact with each other, and the phenotype of the double mutation is consistent with that of <italic>FANCA</italic> or <italic>FANCG</italic> single mutation, but with a higher degree of harm (<xref ref-type="bibr" rid="B132">132</xref>). From this, it can be seen that the FANCA-FANCG complex has a regulatory effect on DNA interstrand cross-linking repair and can lead to NOA by affecting the cell proliferation cycle, especially the meiosis process of sperm.</p>
</sec>
<sec id="s4_1_3">
<label>4.1.3</label>
<title><italic>FANCB</italic>
</title>
<p>The <italic>FANCB</italic> gene is currently the only known FA gene located on the X chromosome. However most current research focuses on the relationship between this gene and female ovaries, breasts, and other aspects and the research on male azoospermia is scarce. The effects of FANCB on male reproduction can be attributed to two pathways. The first pathway is for FANCB can accumulate in spermatogonia and participate in the maintenance of undifferentiated spermatogonia (<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B48">48</xref>). Kato et&#xa0;al. found that the number of PGCs in male <italic>Fancb</italic>-mutant mice was significantly reduced compared with that in the control group, and infertility occurred (<xref ref-type="bibr" rid="B47">47</xref>). As PGCs decreased, the number of spermatogonial cells that divided into spermatogonia also decreased, leading to a decrease in sperm count and the occurrence of NOA. The second pathway is that FANCB can participate in DNA damage repair, ensuring normal meiosis. Studies have shown that the FA core complex cannot ubiquitinate FANCD2 because of the mutant <italic>FANCB</italic>, which leads to the failure of ICL repair. This prevents normal homologous recombination (HR) and sister chromosome exchange (SCEs), leading to failure of division (<xref ref-type="bibr" rid="B18">18</xref>). Therefore, the <italic>FANCB</italic> mutation decreases the number of spermatogonia in male testes and may reduce the success rate of meiosis by hindering the repair of ICL and meiotic recombination process, inducing NOA.</p>
</sec>
<sec id="s4_1_4">
<label>4.1.4</label>
<title><italic>FANCC</italic>
</title>
<p>The expression product of the <italic>FANCC</italic> gene exists in the cytoplasm and nuclear compartments (<xref ref-type="bibr" rid="B133">133</xref>). As a core complex of FA, the function of FANCC to repair DNA damage can maintain the activity of sperms and ensure their survival (<xref ref-type="bibr" rid="B19">19</xref>). FANCC does not change during the cell cycle, but there is a certain degree of dependent regulation (<xref ref-type="bibr" rid="B133">133</xref>). Nadler et&#xa0;al. found that mutations in the <italic>FANCC</italic> gene can interfere with the mitotic process of PGCs, and in males, these exhibit infertility (<xref ref-type="bibr" rid="B49">49</xref>). FANCC participates in the ubiquitination process of the FA core complex (<xref ref-type="bibr" rid="B50">50</xref>). A mutation in this gene will result in the inability of the FA core complex to ubiquitinate, inactivating the FA pathway and preventing it from participating in replication fork stability and cytoplasmic division, which may further lead to the inability of primordial germ cells to undergo mitosis and meiosis. The division of primordial germ cells is impaired, preventing the formation of mature sperm. In experiments in mice, mice with <italic>Fancc</italic> gene mutations experienced a significant decrease in the number of sperms within more than ten days (<xref ref-type="bibr" rid="B49">49</xref>). PGCs are precursors of sperm, and a decrease in PGCs indicates a corresponding decrease in the number of subsequently produced sperm (<xref ref-type="bibr" rid="B134">134</xref>). Low sperm count leads to a series of male infertility diseases such as NOA.</p>
</sec>
<sec id="s4_1_5">
<label>4.1.5</label>
<title><italic>FANCE</italic>
</title>
<p>The product of the <italic>FANCE</italic> gene is a member of the FA core complex (<xref ref-type="bibr" rid="B50">50</xref>), which is mainly involved in ICL repair. Fu et&#xa0;al. (<xref ref-type="bibr" rid="B52">52</xref>) reported very few spermatocytes in the <italic>Fance</italic> mutant mouse model, and that spermatocytes are directly related to spermatogenesis. Therefore, similar to NOA, <italic>Fance</italic> deficiency significantly reduces the sperm count, leading to impaired reproductive function and infertility symptoms in male mice (<xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B135">135</xref>). Research has shown that FANCE participates in ICL repair through both direct and indirect pathways. In the direct pathway, FANCE can ubiquitinate FANCD2 in the S phase and participate in the assembly of FA complexes (<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B53">53</xref>). Then, FANCD2 locates the DNA damage site and recruits FA protein for ICL repair (<xref ref-type="bibr" rid="B51">51</xref>). In the indirect pathway, FANCE and FANCC participate in each other&#x2019;s nuclear accumulation and form the FANCE/FANCC complex regulated by FANCF (<xref ref-type="bibr" rid="B54">54</xref>)to participate in the FA pathway (<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B56">56</xref>). After <italic>FANCE</italic> mutation, FANCC cannot accumulate in the nucleus, FA complex cannot assemble (<xref ref-type="bibr" rid="B22">22</xref>), and FANCD2 cannot complete ubiquitination, ultimately leading to ICL repair failure. Data shows that <italic>FANCE</italic> mutations can arrest the cell division cycle (<xref ref-type="bibr" rid="B57">57</xref>). Loss of <italic>FANCE</italic> leads to increase cell mortality rate, and cause difficulty in spermatogenesis, often resulting in NOA (<xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B57">57</xref>). Simultaneously, cell cycle arrest can affect the development of spermatogonial stem cells (<xref ref-type="bibr" rid="B136">136</xref>). As the earliest sperm cells, spermatogonial stem cells are of great significance in male reproduction. Therefore, <italic>FANCE</italic> deficiency can lead to cell cycle arrest, affect spermatocyte and sperm development, and lead to NOA.</p>
</sec>
<sec id="s4_1_6">
<label>4.1.6</label>
<title><italic>FANCF</italic>
</title>
<p>FANCF mainly exists in the nucleus and is an important component of the core complex that constitutes the FA pathway, playing a protective role on the genome (<xref ref-type="bibr" rid="B21">21</xref>). FANCF is an adapter protein and has two relatively stable regions located at the N-terminus and C-terminus. The C-terminal binding of FANCG to FANCF seems more stable, while the FANCC/FANCE complex can bind to the N-terminal of FANCF (<xref ref-type="bibr" rid="B54">54</xref>). In this way, FANCF protein tightly binds to other core complex components to maintain the stability of the FA core complex and promote the ubiquitination of the ID2 complex (<xref ref-type="bibr" rid="B58">58</xref>). Compared with other Fanconi genes, many mechanisms of <italic>FANCF</italic> are not yet clear. Previous studies have shown that <italic>FANCF</italic> mutations can cause instability in the FA genome, damaging the gonads (<xref ref-type="bibr" rid="B59">59</xref>). According to relevant data (<xref ref-type="bibr" rid="B137">137</xref>), <italic>FANCF</italic> defects can cause testicular lesions and testicular cancer. Spermatogonia develop into sperm in the seminiferous tubules within the testicles (<xref ref-type="bibr" rid="B138">138</xref>) <sup>(</sup>
<xref ref-type="bibr" rid="B139">139</xref><sup>),</sup>. Therefore, mutations in <italic>FANCF</italic> can further damage the seminiferous tubules by causing testicular damage and making them unable to provide a place for sperm production, resulting in immature sperm development and ultimately NOA. Furthermore, Mutations in <italic>FANCF</italic> protect the crossover phenomenon of DNA, making it difficult to repair its function and adversely affecting fertility (<xref ref-type="bibr" rid="B140">140</xref>). Therefore, the deletion of the <italic>FANCF</italic> gene not only causes testicular lesions, causing difficulty in spermatogenesis, but also affects seminiferous tubules, leading to NOA.</p>
</sec>
<sec id="s4_1_7">
<label>4.1.7</label>
<title><italic>FANCL/FANCT (UBE2T)</italic>
</title>
<p><italic>FANCL</italic> encodes the FA core complex protein E3 ubiquitin ligase (<xref ref-type="bibr" rid="B141">141</xref>), and its encoded product plays an important role in DNA damage repair. <italic>FANCT</italic>, also known as <italic>UBE2T</italic>, encodes E2 ubiquitin-conjugating enzyme (<xref ref-type="bibr" rid="B142">142</xref>). The complex formed by FANCL/FANCT (E2-E3) (<xref ref-type="bibr" rid="B25">25</xref>) is the only known complex that directly regulates FANCD2-FANCI (ID2) and positively affects the ubiquitination of ID2 complexes. This complex can reduce the DNA interstrand cross-links to a certain extent, inhibit DNA segment crossovers that occur in some cells during DNA replication, and ensure the stability of cellular genetics (<xref ref-type="bibr" rid="B61">61</xref>). FANCD2, as a key factor in activating the FA pathway, appears around the nucleus of S-phase PGCs in normal development, indicating a correlation between the FA pathway and fertility (<xref ref-type="bibr" rid="B62">62</xref>). Although there are not many reports on these two genes in NOA diseases, we can speculate based on the above research results that <italic>UBE2T</italic> mutation or knockout will result in disorder in the PGCs in DNA replication and also affect normal mitosis (<xref ref-type="bibr" rid="B62">62</xref>), and <italic>FANCL</italic> mutations may cause apoptosis in a large number of sperms in the seminiferous tubules, and resulting in a sudden decrease in sperm. Therefore, both <italic>FANCL</italic> and <italic>FANCT</italic> defects can damage sperm formation and lead to NOA in men (<xref ref-type="bibr" rid="B143">143</xref>).</p>
</sec>
</sec>
<sec id="s4_2">
<label>4.2</label>
<title>The effect of ID2 defect on NOA</title>
<p>FANCD2 is one of the most conserved members of the FA family, and its mono-ubiquitination is key to activating the FA pathway. FANCD2 can interact with other proteins to repair DNA damage and play an important role in many stages of cell development (<xref ref-type="bibr" rid="B144">144</xref>, <xref ref-type="bibr" rid="B145">145</xref>). FANCI is mainly located in the nucleolus and can regulate the transcription of ribosomes, maintaining the relative stability of DNA (<xref ref-type="bibr" rid="B146">146</xref>, <xref ref-type="bibr" rid="B147">147</xref>). FANCD2 and FANCI combine to form an ID2 complex, both of which are mono-ubiquitinated substrates (<xref ref-type="bibr" rid="B21">21</xref>). ICL cannot be repaired without the activation of the FA pathway, and this depends on the mono-ubiquitination of FANCD2 and FANCI, which activates the downstream FA pathway (<xref ref-type="bibr" rid="B148">148</xref>, <xref ref-type="bibr" rid="B149">149</xref>). At the molecular level, the ubiquitinated ID2 complex initiates downstream processes such as nucleotide cleavage and homologous recombination, while at the cellular level, it activates the cell cycle to continue dividing (<xref ref-type="bibr" rid="B63">63</xref>). Ubiquitination binds the ID2 complex more firmly in space, thus better protecting damaged DNA from external interference and ensuring normal DNA damage response and repair (<xref ref-type="bibr" rid="B64">64</xref>). Moreover, by phosphorylating FANCI with ATR kinase, the ID2 complex can maintain its ubiquitination (<xref ref-type="bibr" rid="B150">150</xref>). After participating in the FA pathway, the ID2 complex needs to be immediately de-ubiquitinated, which is mediated by the ubiquitin-specific peptidase USP1. Blocking the de-ubiquitination process will lead to the failure of chromosomal homologous recombination and&#xa0;the&#xa0;inability to produce spermatogenic cells (<xref ref-type="bibr" rid="B151">151</xref>). Hypospermatogenesis is the testicular phenotype of patients with NOA (<xref ref-type="bibr" rid="B152">152</xref>). Furthermore, in mice with <italic>Fancd2</italic> deficiency, double strand break (DSB) and crossovers cannot be repaired in a timely manner, resulting in genetic information damage to PGCs during division and minimal sperm count (<xref ref-type="bibr" rid="B65">65</xref>). Simultaneously, mutated <italic>FANCI</italic> will induce FANCD2 lesions and lead to a decrease in the number of undifferentiated spermatocytes, which may develop into NOA (<xref ref-type="bibr" rid="B143">143</xref>). In summary, the ubiquitination, ATM and Rad3-related phosphorylation, and de-ubiquitination processes of the ID2 complex are indispensable. A mistake in any link can seriously affect downstream homologous recombination processes (<xref ref-type="bibr" rid="B69">69</xref>), leading to ICL repair failure and affecting the normal development of male testes (<xref ref-type="bibr" rid="B66">66</xref>), thereby inducing NOA.</p>
</sec>
<sec id="s4_3">
<label>4.3</label>
<title>The effect of ID2 ubiquitination downstream defects on NOA</title>
<sec id="s4_3_1">
<label>4.3.1</label>
<title>The effect of nucleolysis-related genes on NOA</title>
<sec id="s4_3_1_1">
<label>4.3.1.1</label>
<title><italic>FANCP</italic>
</title>
<p><italic>FANCP</italic>, also known as <italic>SLX4</italic>, encodes a large scaffold protein that assists structure-specific endonucleases. This protein is important in maintaining gene stability in repairing various types of DNA damage, such as DNA interstrand cross-links (<xref ref-type="bibr" rid="B29">29</xref>). This gene is precisely located in pachytene sex chromatin and is closely related to the genetic stability of sex chromosomes (<xref ref-type="bibr" rid="B153">153</xref>). The more stable the inheritance of XY chromatin, the stronger the SLX4 intensity and the more complete the genetic material possessed by the sperm (<xref ref-type="bibr" rid="B153">153</xref>, <xref ref-type="bibr" rid="B154">154</xref>). We believe that the probability of NOA occurring in a stable genetic environment will also be minimal. In the process of repairing interchain crosslinks, FANCP decouple the cross-linked portion (<xref ref-type="bibr" rid="B67">67</xref>). FANCP (SLX4) acts as a scaffold protein and acts on DNA strand cross-linking through the UBZ-1 domain to release the cross-linked portion (<xref ref-type="bibr" rid="B68">68</xref>). Simultaneously, this protein can effectively inhibit the intermediate produced by homologous recombination, and SLX4IP regulates the SLX4-XPF-ERCC1 complex, which can, to some extent, inhibit ICL (<xref ref-type="bibr" rid="B68">68</xref>). FANCP regulates the correct segregation of chromosomes within PGCs. Furthermore, research has found that the absence of <italic>SLX4</italic> can lead to the abnormal development of spermatogonia, which cannot develop into mature sperm in the seminiferous tubules (<xref ref-type="bibr" rid="B139">139</xref>), and the number of sperm decreases. A low number of mature sperm can lead to a low number of sperm in the seminal vesicles, resulting in NOA (<xref ref-type="bibr" rid="B155">155</xref>). We speculate that if <italic>SLX4</italic> undergoes mutations or deletions, the meiotic process may be halted owing to genetic instability, resulting in the inability to produce sperm and NOA or oligospermia.</p>
</sec>
<sec id="s4_3_1_2">
<label>4.3.1.2</label>
<title><italic>FANCQ</italic>
</title>
<p><italic>FANCQ</italic>, also known as <italic>ERCC4 (</italic>
<xref ref-type="bibr" rid="B156">156</xref>), encodes a protein mainly involved in the repair of ICL. FANCQ plays a role downstream of the FA pathway. XPF expressed through ERCC4 can form a complex with ERCC1, which is recruited by SLX4 with the help of FANCD2 mono-ubiquitination and directly acts on the ICL repair site (<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B69">69</xref>). In contrast, <italic>ERCC4</italic> expresses a specific nuclease XPF that participates in the nucleotide excision repair necessary for ICL repair, thereby indirectly participating in ICL repair (<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B70">70</xref>). <italic>FANCQ</italic> mutations exhibit cell cycle arrest induced by mitomycin C, which may be due to chromosome breakage caused by ICL repair defects (<xref ref-type="bibr" rid="B71">71</xref>, <xref ref-type="bibr" rid="B72">72</xref>). Therefore, <italic>FANCQ</italic> mutations may disrupt the process of sperm production or reduce the number of sperm, and hypospermatogenesis and cell maturity arrest are the histological phenotypes of the testicles in NOA (<xref ref-type="bibr" rid="B157">157</xref>). Furthermore, FANCQ also plays an important role in the meiotic recombination process. The SHOC1 protein is an ERCC4-like protein, and plays a role in the meiotic process of spermatocytes, promoting the formation of crossovers and ensuring correct chromosome separation to produce haploid gametes, and the ERCC4 protein also has this function (<xref ref-type="bibr" rid="B73">73</xref>, <xref ref-type="bibr" rid="B74">74</xref>). Therefore, <italic>FANCQ</italic> mutations may result in chromosome recombination errors during meiosis and arrest the spermatocyte cycle (<xref ref-type="bibr" rid="B73">73</xref>, <xref ref-type="bibr" rid="B74">74</xref>). We summarized the possible effects of FANCQ on NOA pathogenesis. FANCQ plays important roles in ICL repair and meiotic recombination. <italic>FANCQ</italic> mutation may prevent ICL repair, cause meiotic recombination errors, and hinder the spermatocyte division cycle, leading to apoptosis, and then lead to hypospermatogenesis often leads to NOA (<xref ref-type="bibr" rid="B72">72</xref>).</p>
</sec>
</sec>
<sec id="s4_3_2">
<label>4.3.2</label>
<title>The effect of TLS-related genes on NOA</title>
<sec id="s4_3_2_1">
<label>4.3.2.1</label>
<title><italic>FANCV</italic>
</title>
<p><italic>FANCV</italic>, also known as <italic>REV7</italic>/<italic>MAD2L2 (</italic>
<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B75">75</xref>), encodes a protein that can form a DNA polymerase complex with REV3 (<xref ref-type="bibr" rid="B76">76</xref>), enabling FANCV to greatly promote REV3&#x2019;s ability to repair DNA damage and play an expanding role in ICL repair in the form of enzymes (<xref ref-type="bibr" rid="B77">77</xref>, <xref ref-type="bibr" rid="B78">78</xref>). ICL repair is closely related to spermatogenesis, indicating the importance of FANCV in regulating cell mitosis and cell development. Experimental reports show the extreme abundance of REV7 in adult male testes (<xref ref-type="bibr" rid="B158">158</xref>). After the deletion of this gene, the number of PGCs in mice decreases and they exhibit infertility (<xref ref-type="bibr" rid="B79">79</xref>). Furthermore, studies have shown that after <italic>FANCV</italic> mutation, PGCs undergo apoptosis during the embryonic stage, resulting in spermatogenesis defects and testicular sperms are underdeveloped (<xref ref-type="bibr" rid="B75">75</xref>). The structural domain mutations in the interaction between FANCV and REV3 manifest as cell cycle arrest, chromosome breakage, and difficulty in cell proliferation, leading to difficulty in spermatogenesis (<xref ref-type="bibr" rid="B80">80</xref>). Therefore, REV7 can maintain the normal morphology and function of sperms, and <italic>FANCV</italic> mutations can lead to sperm maturity arrest, leading to NOA (<xref ref-type="bibr" rid="B157">157</xref>).</p>
</sec>
</sec>
<sec id="s4_3_3">
<label>4.3.3</label>
<title>The effect of homologous recombination related genes on NOA</title>
<p>Homologous recombination is important in chromosomal inheritance and DNA repair during mitosis and meiosis. Homologous recombination maintains genome stability by regulating damaged replication forks or filling DNA gaps, and can be used to repair DNA double-strand break (<xref ref-type="bibr" rid="B159">159</xref>, <xref ref-type="bibr" rid="B160">160</xref>). Studies have shown that the FA pathway can also repair DNA damage (<xref ref-type="bibr" rid="B161">161</xref>), and many genes in the FA gene family are involved in homologous recombination processes, such as <italic>FANCR</italic> (<italic>RAD51</italic>), <italic>FANCS</italic> (<italic>BRCA1</italic>), <italic>FANCD1</italic> (<italic>BRCA2</italic>), and other genes that encode crucial homologous recombination proteins (<xref ref-type="bibr" rid="B162">162</xref>). Homologous recombination repair affects spermatogonial stem cells and may be associated with NOA (<xref ref-type="bibr" rid="B163">163</xref>).</p>
<sec id="s4_3_3_1">
<label>4.3.3.1</label>
<title><italic>FANCN</italic>
</title>
<p><italic>FANCN</italic>, also known as <italic>PALB2</italic>, encodes a gene product that can participate in homologous recombination repair, which is related to the repair of ICL and the smooth progression of the cell cycle (<xref ref-type="bibr" rid="B27">27</xref>). Cell cycle arrest and cell apoptosis often cause NOA. FANCN recruits DNA damage sites by connecting one end of the coil domain to FANCS (BRCA1), while the other end recruits FANCD1 (BRCA2) and FANCR (RAD51) to DNA damage sites to initiate homologous recombination repair (<xref ref-type="bibr" rid="B82">82</xref>). Furthermore, phosphorylation of FANCN by the cell cycle checkpoint regulatory factor ataxia telangiectasia mutated can promote the repair process&#xa0;of homologous recombination by RAD51 (<xref ref-type="bibr" rid="B164">164</xref>, <xref ref-type="bibr" rid="B165">165</xref>). The&#xa0;n-terminal mutation of FANCN prevents homologous recombination repair involving FANCN (<xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B83">83</xref>). According to Simhadri et&#xa0;al., removing the <italic>Palb2</italic> gene in mice can lead to a significant reduction or apoptosis of male sperms, affecting fertility (<xref ref-type="bibr" rid="B81">81</xref>). Defects in homologous recombination repair of cells can hinder chromosomal recombination during decelerative division,&#xa0;and spermatocytes exhibit cell cycle arrest (<xref ref-type="bibr" rid="B81">81</xref>). Male spermatogonial stem cells will gradually develop into sperm (<xref ref-type="bibr" rid="B166">166</xref>), and in mice lacking <italic>Palb2</italic>, the number of spermatogonial stem cells significantly decreases. We speculate that the number of male sperms lacking this gene will also show a downward trend, resulting in a sudden decrease in the number of sperm formed in the future. Therefore, FANCN mutations may be potential risk factors for NOA.</p>
</sec>
<sec id="s4_3_3_2">
<label>4.3.3.2</label>
<title><italic>FANCS</italic>
</title>
<p><italic>FANCS</italic>, also known as <italic>BRCA1 (</italic>
<xref ref-type="bibr" rid="B167">167</xref>), encodes a protein that is important in DNA damage repair and transcriptional regulation (<xref ref-type="bibr" rid="B168">168</xref>, <xref ref-type="bibr" rid="B169">169</xref>), and can also maintain genomic integrity and stability by participating in cellular DNA damage repair (<xref ref-type="bibr" rid="B32">32</xref>). Research has shown that BRCA1 can interact with Werner syndrome protein to jointly repair ICL (<xref ref-type="bibr" rid="B170">170</xref>). According to Durocher et&#xa0;al., the <italic>BRCA1</italic> gene is present in interstitial cells of the testis, and <italic>BRCA1</italic> deficiency can lead to impaired expression in interstitial cells of the testis (<xref ref-type="bibr" rid="B171">171</xref>). Interstitial cells of the testis play a controlling role in male fertility, and if damaged, they can lead to a decrease in sperm quality and quantity (<xref ref-type="bibr" rid="B172">172</xref>). Therefore, mutations in <italic>BRCA1</italic> damage interstitial cells of the testis, further affecting sperm count and indirectly leading to NOA. Furthermore, research has found that when <italic>FANCS</italic> mutates, the testicular volume significantly decreases, the seminiferous tubules cannot produce sperm, and the expression of genes related to the repair of DNA damage is reduced, making it difficult to repair damaged spermatocytes in a timely manner (<xref ref-type="bibr" rid="B86">86</xref>). Sciurano et&#xa0;al. found that spermatocyte division was stagnant and spermatocyte death occurred in a patient with azoospermia (<xref ref-type="bibr" rid="B173">173</xref>). Therefore, patients with <italic>FANCS</italic> mutations are likely to further develop NOA due to irreversible damage to spermatocytes.</p>
</sec>
<sec id="s4_3_3_3">
<label>4.3.3.3</label>
<title><italic>FANCD1</italic>
</title>
<p><italic>BRCA2</italic>, also known as <italic>FANCD1</italic>, encodes a protein that regulates the RAD51 protein by participating in ID2 ubiquitination and binding to DNA, thereby participating in homologous recombination repair processes (<xref ref-type="bibr" rid="B87">87</xref>, <xref ref-type="bibr" rid="B88">88</xref>). BRCA2 can control the stability of the genome while maintaining normal meiotic processes, playing an important role in the maturation and development of sperms (<xref ref-type="bibr" rid="B174">174</xref>). Studies have shown that BRCA2 is associated with male azoospermia and plays a controlling role in meiosis (<xref ref-type="bibr" rid="B89">89</xref>). <italic>BRCA2</italic> deficiency can lead to a meiotic disorder in spermatocytes, leading to infertility and directly affecting spermatogenesis, leading to male azoospermia or oligospermia (<xref ref-type="bibr" rid="B89">89</xref>). Shukron et&#xa0;al. compared the structure of male fruit flies with <italic>Brca2</italic> homozygous and heterozygous deletions, as well as wild-type fruit flies, and found that male fruit flies with homozygous mutations experienced sperm arrest, testicular development abnormalities, and infertility (<xref ref-type="bibr" rid="B175">175</xref>). Shive et&#xa0;al. found oligospermia in male zebrafish in a homozygous mutation model of <italic>Brca2 (</italic>
<xref ref-type="bibr" rid="B176">176</xref>). Simultaneously, a report showed that homozygous deletion of <italic>FANCD1</italic> resulted lower sperm maturation (<xref ref-type="bibr" rid="B90">90</xref>). Therefore, mutated <italic>FANCD1</italic> may lead to the failure of ICL repair, meiosis stagnation at the S-phase checkpoint, failure of the spermatocyte-to-sperm process to proceed normally, gradual apoptosis, and oligospermia or aspermia (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B87">87</xref>, <xref ref-type="bibr" rid="B89">89</xref>).</p>
</sec>
<sec id="s4_3_3_4">
<label>4.3.3.4</label>
<title><italic>FANCO</italic> and <italic>FANCR</italic>
</title>
<p><italic>FANCO</italic> is also known as <italic>RAD51C</italic>, and <italic>FANCR</italic> is also known as <italic>RAD51 (</italic>
<xref ref-type="bibr" rid="B177">177</xref>). FANCO, a newly isolated member of the RAD51 (FANCR) family, shares genetic similarities with other members. Therefore, RAD51C is a collateral homolog of RAD51 (<xref ref-type="bibr" rid="B178">178</xref>). Both play important roles in repairing DNA interstrand cross-links. In DNA damage, overexpression of the RAD51 paraprotein XRCC3 increases resistance to ICL inducers, while RAD51C binds to XRCC3 to form a complex dependent on RAD51 to ensure proper chromosome separation during meiosis (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B91">91</xref>, <xref ref-type="bibr" rid="B92">92</xref>). Mutation or deletion of <italic>RAD51C</italic> can enhance the sensitivity of cross-linking between DNA strands (<xref ref-type="bibr" rid="B93">93</xref>), and RAD51C can transmit DNA damage signals to induce DNA damage repair (<xref ref-type="bibr" rid="B179">179</xref>). Some studies have found that <italic>RAD51</italic> mutants develop azoospermia due to meiosis termination (<xref ref-type="bibr" rid="B95">95</xref>). Simultaneously, in a mouse model, Qin et&#xa0;al. found (<xref ref-type="bibr" rid="B180">180</xref>) that the knockout of <italic>Rad51</italic> led to abnormal development of spermatogonocytes, a reduced number of pachytene spermatocytes, or apoptosis. If defective <italic>RAD51</italic> results in a reduced sperm count, NOA is further increased. Similarly, mutations in <italic>RAD51C</italic> can induce the suspension of spermatocyte development, which mainly occurs in the first phase of meiotic division and is related to abnormal chromosome breakage or premature sister chromosome separation (<xref ref-type="bibr" rid="B94">94</xref>). The further development of meiotic arrest in spermatocytes may result in NOA (<xref ref-type="bibr" rid="B173">173</xref>) Therefore, FANCO and FANCR are interdependent, ensuring normal progression of meiosis. If both mutations occur, they can affect spermatogonia and spermatocytes, causing NOA.</p>
</sec>
<sec id="s4_3_3_5">
<label>4.3.3.5</label>
<title><italic>FANCU</italic>
</title>
<p>The alias of <italic>FANCU</italic> is <italic>XRCC2</italic>, and its expression product can form a complex BCDX2 with FANCR (RAD51) homologous compounds (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B178">178</xref>, <xref ref-type="bibr" rid="B181">181</xref>). This complex plays a role in replication restart in homologous recombination repair (<xref ref-type="bibr" rid="B96">96</xref>). <italic>FANCU</italic> mutation reduces the stability of BCDX2 (<xref ref-type="bibr" rid="B96">96</xref>), resulting in the collapse of the replication fork due to the inability to restart, resulting in chromosome breakage and forced termination of cell division (<xref ref-type="bibr" rid="B97">97</xref>, <xref ref-type="bibr" rid="B98">98</xref>). Sanger sequencing of <italic>Fancu</italic> mutant mice revealed a recessive mutation in <italic>Fancu</italic> (C. 41T&gt;C/p.Leu14Pro), which stopped the meiosis of cells, thus leading to azoospermia (<xref ref-type="bibr" rid="B95">95</xref>). BCDX2 complex participates in the formation of RAD51 nuclear protein filament by binding with single-stranded DNA, and plays a role in double-strand break repair in the assembly of RAD51 lesions (<xref ref-type="bibr" rid="B33">33</xref>). <italic>FANCU</italic> mutant cells showed defects in homologous recombination damage repair (<xref ref-type="bibr" rid="B99">99</xref>). Simultaneously, Zhang et&#xa0;al. used whole-exome sequencing to sequence two patients with infertility and found that male patients with NOA had C. 41T&gt;C (p.Leu14Pro) <italic>XRCC2</italic> mutation, and believed that the occurrence of NOA in the family was caused by <italic>XRCC2</italic> mutation (<xref ref-type="bibr" rid="B182">182</xref>). Therefore, we concluded that the mutation of <italic>FANCU</italic> led to the defective assembly of RAD51 lesions, which resulted in the failure of homologous recombination repair and apoptosis (<xref ref-type="bibr" rid="B99">99</xref>). The consequence of incomplete spermatocyte division may be sperm apoptosis, resulting in NOA.</p>
</sec>
<sec id="s4_3_3_6">
<label>4.3.3.6</label>
<title><italic>FANCW</italic>
</title>
<p><italic>FANCW</italic>, also known as <italic>RFWD3</italic>, encodes a protein that plays a role in the synthesis of homologous recombination repair DNA (<xref ref-type="bibr" rid="B87">87</xref>). After binding to RPA, the C-terminal of FANCW is recruited by RPA to the stalled replication fork, and the protein is phosphorylated by checkpoint kinase Ataxia-telangiectasia mutated (ATM) and Rad3-related (ATR) to participate in the ATM/ATR signaling pathway and control the DNA replication checkpoint to restart the replication fork (<xref ref-type="bibr" rid="B100">100</xref>&#x2013;<xref ref-type="bibr" rid="B104">104</xref>). FANCW accelerates the separation of RPA from single-stranded DNA by regulating its ubiquitination (<xref ref-type="bibr" rid="B105">105</xref>), while also promoting the recruitment of repair proteins such as RAD51 and RAD52 by RPA, enabling them to jointly locate DNA damage sites and initiate RAD51-mediated homologous recombination repair (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B183">183</xref>). This may be due to the <italic>FANCW</italic> mutation, which prevents isolation of RPA from the RAD51 lesion, prevents the formation of RAD51 nuclear filaments, and leads to cell cycle arrest (<xref ref-type="bibr" rid="B105">105</xref>, <xref ref-type="bibr" rid="B106">106</xref>). Cell cycle arrest greatly affects the development of spermatogonial stem cells, causing them to stagnate, unable to produce spermatogonial cells or sperm, resulting in a decreased sperm count (<xref ref-type="bibr" rid="B136">136</xref>). Simultaneously, the interaction between spermatogonial stem cells and Sertoli cells is regulated, and Sertoli cells promote the maturation and development of testicular seminiferous tubules (<xref ref-type="bibr" rid="B166">166</xref>). Although there is currently no relevant literature on <italic>FANCW</italic> mutations directly leading to NOA, we speculate that <italic>FANCW</italic> defects can cause low sperm levels and immature spermatogenic tubules, affecting the maturation and development of spermatogonial stem cells and supporting cells, thereby inducing NOA.</p>
</sec>
<sec id="s4_3_3_7">
<label>4.3.3.7</label>
<title><italic>FANCJ</italic>
</title>
<p>The <italic>FANCJ</italic> gene is called <italic>BRIP1</italic> or <italic>BACH1 (</italic>
<xref ref-type="bibr" rid="B184">184</xref>). The protein encoded by this gene acts DNA helicase and plays an important role in repairing ICL and DNA DSB through HR (<xref ref-type="bibr" rid="B24">24</xref>). Studies have found that mutated <italic>FANCJ</italic> seriously affects spermatogenesis (<xref ref-type="bibr" rid="B107">107</xref>). Compared with normal cells, cells with <italic>FANCJ</italic> deficiency or lack of FANCJ catalytic activity have an increased sensitivity to DNA ICL (<xref ref-type="bibr" rid="B185">185</xref>), while cells with <italic>FANCJ</italic> mutations significantly reduce their resistance to ICL (<xref ref-type="bibr" rid="B108">108</xref>), resulting in a significant increase in the number of ICL within cells. Furthermore, FANCJ can control the normal division of chromosomes by regulating the replication fork, reducing the destruction of chromatin structure during the replication process, ensuring normal chromatin replication, and maintaining genetic stability (<xref ref-type="bibr" rid="B109">109</xref>). According to experimental studies in mice, FANCJ causes genetic defects or mutations, with only some males exhibiting fertility. However, there is a significant reduction in testicular volume and a sudden decrease in the number of spermatogonial stem cells (<xref ref-type="bibr" rid="B107">107</xref>). NOA is characterized by a low sperm level, whereas spermatogonial stem cells are the most primitive spermatogonial cells, which gradually develop into sperm (<xref ref-type="bibr" rid="B186">186</xref>). Although no direct evidence currently links <italic>FANCJ</italic> mutations to the occurrence of NOA, based on our research, we speculate that <italic>FANCJ</italic> mutations may cause genetic and DNA disorders in primordial germ cells, preventing the formation of normal sperms and leading to NOA.</p>
</sec>
</sec>
</sec>
</sec>
<sec id="s5">
<label>5</label>
<title>Summary and outlook</title>
<p>The treatment methods for infertility, including for NOA, are not mature internationally and can be roughly divided into auxiliary technologies, such as spermatogonial stem cell transplantation and intracytoplasmic sperm injection (<xref ref-type="bibr" rid="B187">187</xref>, <xref ref-type="bibr" rid="B188">188</xref>). The diagnosis and treatment of NOA through the FA pathway has broad research prospects. If activation of the FA pathway fails, it can lead to unstable DNA replication in PGCs, exacerbating their damage and significantly reducing their number during division, leading to NOA or oligospermia in males. Using the FA pathway to repair the ICL and restore the number of mature sperm in the testes of patients with NOA may cure the disease. Mutations in any FA gene may cause irreparable damage to male reproductive function through the FA pathway and may even be fatal. A key step in the FA pathway is successful ubiquitination of the ID2 complex to repair the damage caused by ICL. Activation of the FA pathway controls the rapidly proliferating PGCs to stabilize the replication and transcription of their DNA (<xref ref-type="bibr" rid="B8">8</xref>). At present, relatively novel studies mainly focus on gene level changes such as mRNA therapy and lentiviral vector therapy (<xref ref-type="bibr" rid="B189">189</xref>, <xref ref-type="bibr" rid="B190">190</xref>). At the same time, adeno-associated virus integration site 1 has also been found to guide <italic>FANCA</italic> to target the binding of DNA missing this gene fragment to achieve changes in cell phenotype (<xref ref-type="bibr" rid="B191">191</xref>). In the future, perhaps we can actively encourage genetic testing and premarital physical examination to reduce the birth of NOA children to some extent from the perspective of prevention. For patients who have been clinically diagnosed with NOA, we can use special mRNA or other special carriers to bind the DNA of FA gene defect to make the expression of FA gene complete again, so as to maintain the number of viable sperm in NOA patients. At the same time, the development of FA protein replacement drugs may be of great significance for maintaining the normal function of FA pathway and improving the reproductive defects in NOA patients, and it is expected to become a new therapeutic strategy. This article reviews the correlation between NOA and FA, categorizes them according to the different gene properties, and attempts to elucidate the relevant mechanisms and significance. We hope that this review will be helpful in solving the problems of DNA damage and FA pathway activation failure caused by FA gene mutations and provide new development ideas and concepts for NOA researchers.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author contributions</title>
<p>HX: Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. YZ: Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. CW: Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. ZF: Writing &#x2013; original draft. JL: Writing &#x2013; original draft. YY: Writing &#x2013; original draft. ZZ: Writing &#x2013; review &amp; editing. YQ: Writing &#x2013; review &amp; editing. KM: Writing &#x2013; review &amp; editing. JY: Writing &#x2013; review &amp; editing. XW: Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s7" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by grants from Research Fund for Lin He<bold>&#x2019;</bold>s Academician Workstation of New Medicine and Clinical Translation in Jining Medical University (JYHL2021MS13,JYHL2021MS10), the Research Start-up Fund of Jining Medical University (600791001) and College Students<bold>&#x2019;</bold> Innovation Training Program of Jining Medical University (cx2023136z).</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We thank to Figdraw for providing scientific researchers with exquisite materials and convenient drawing platform. All the figures in this article are made by Figdraw (<ext-link ext-link-type="uri" xlink:href="http://www.figdraw.com">www.figdraw.com</ext-link>).</p>
</ack>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krausz</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Male infertility: pathogenesis and clinical diagnosis</article-title>. <source>Best Pract Res Clin Endocrinol Metab</source>. (<year>2011</year>) <volume>25</volume>:<page-range>271&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.beem.2010.08.006</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wosnitzer</surname> <given-names>M</given-names>
</name>
<name>
<surname>Goldstein</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hardy</surname> <given-names>MP</given-names>
</name>
</person-group>. <article-title>Review of azoospermia</article-title>. <source>Spermatogenesis</source>. (<year>2014</year>) <volume>4</volume>:<elocation-id>e28218</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.4161/spmg.28218</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agarwal</surname> <given-names>A</given-names>
</name>
<name>
<surname>Baskaran</surname> <given-names>S</given-names>
</name>
<name>
<surname>Parekh</surname> <given-names>N</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>C-L</given-names>
</name>
<name>
<surname>Henkel</surname> <given-names>R</given-names>
</name>
<name>
<surname>Vij</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Male infertility</article-title>. <source>Lancet</source>. (<year>2021</year>) <volume>397</volume>:<page-range>319&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(20)32667-2</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arshad</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Majzoub</surname> <given-names>A</given-names>
</name>
<name>
<surname>Esteves</surname> <given-names>SC</given-names>
</name>
</person-group>. <article-title>Predictors of surgical sperm retrieval in non-obstructive azoospermia: summary of current literature</article-title>. <source>Int Urol Nephrol</source>. (<year>2020</year>) <volume>52</volume>:<page-range>2015&#x2013;38</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11255-020-02529-4</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klami</surname> <given-names>R</given-names>
</name>
<name>
<surname>Mankonen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Perheentupa</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Successful microdissection testicular sperm extraction for men with non-obstructive azoospermia</article-title>. <source>Reprod Biol</source>. (<year>2018</year>) <volume>18</volume>:<page-range>137&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.repbio.2018.03.003</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hill</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Crossan</surname> <given-names>GP</given-names>
</name>
</person-group>. <article-title>DNA cross-link repair safeguards genomic stability during premeiotic germ cell development</article-title>. <source>Nat Genet</source>. (<year>2019</year>) <volume>51</volume>:<page-range>1283&#x2013;94</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41588-019-0471-2</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pickering</surname> <given-names>A</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Panneerselvam</surname> <given-names>J</given-names>
</name>
<name>
<surname>Fei</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Advances in the understanding of the Fanconi anemia tumor suppressor pathway</article-title>. <source>Cancer Biol Ther</source>. (<year>2013</year>) <volume>14</volume>:<page-range>1089&#x2013;91</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4161/cbt.26380</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>F</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>S</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Transcription&#x2013;replication conflicts in primordial germ cells necessitate the Fanconi anemia pathway to safeguard genome stability</article-title>. <source>Proc Natl Acad Sci</source>. (<year>2022</year>) <volume>119</volume>:<elocation-id>e2203208119</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.2203208119</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwong</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ho</surname> <given-names>CY</given-names>
</name>
<name>
<surname>Shin</surname> <given-names>VY</given-names>
</name>
<name>
<surname>Au</surname> <given-names>CH</given-names>
</name>
<name>
<surname>Chan</surname> <given-names>TL</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>ES</given-names>
</name>
</person-group>. <article-title>A case report of germline compound heterozygous mutations in the BRCA1 gene of an ovarian and breast cancer patient</article-title>. <source>Int J Mol Sci</source>. (<year>2021</year>) <volume>22</volume>:<fpage>889</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms22020889</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daum</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zlotogora</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Fanconi anemia gene variants in patients with gonadal dysfunction</article-title>. <source>Reprod Sci</source>. (<year>2022</year>) <volume>29</volume>:<page-range>1408&#x2013;13</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s43032-021-00582-7</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Auerbach</surname> <given-names>AD</given-names>
</name>
</person-group>. <article-title>Fanconi anemia and its diagnosis</article-title>. <source>Mutat Res/Fundamental Mol Mech Mutagenesis</source>. (<year>2009</year>) <volume>668</volume>:<fpage>4</fpage>&#x2013;<lpage>10</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mrfmmm.2009.01.013</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krausz</surname> <given-names>C</given-names>
</name>
<name>
<surname>Riera-Escamilla</surname> <given-names>A</given-names>
</name>
<name>
<surname>Chianese</surname> <given-names>C</given-names>
</name>
<name>
<surname>Moreno-Mendoza</surname> <given-names>D</given-names>
</name>
<name>
<surname>Ars</surname> <given-names>E</given-names>
</name>
<name>
<surname>Rajmil</surname> <given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>From exome analysis in idiopathic azoospermia to the identification of a high-risk subgroup for occult Fanconi anemia</article-title>. <source>Genet Med</source>. (<year>2019</year>) <volume>21</volume>:<page-range>189&#x2013;94</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41436-018-0037-1</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsui</surname> <given-names>V</given-names>
</name>
<name>
<surname>Crismani</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>The Fanconi anemia pathway and fertility</article-title>. <source>Trends Genet</source>. (<year>2019</year>) <volume>35</volume>:<fpage>199</fpage>&#x2013;<lpage>214</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tig.2018.12.007</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Degan</surname> <given-names>P</given-names>
</name>
<name>
<surname>Cappelli</surname> <given-names>E</given-names>
</name>
<name>
<surname>Regis</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ravera</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>New insights and perspectives in Fanconi anemia research</article-title>. <source>Trends Mol Med</source>. (<year>2019</year>) <volume>25</volume>:<page-range>167&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molmed.2019.01.003</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ekundayo</surname> <given-names>B</given-names>
</name>
<name>
<surname>Bleichert</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Origins of DNA replication</article-title>. <source>PloS Genet</source>. (<year>2019</year>) <volume>15</volume>:<elocation-id>e1008320</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pgen.1008320</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Milletti</surname> <given-names>G</given-names>
</name>
<name>
<surname>Strocchio</surname> <given-names>L</given-names>
</name>
<name>
<surname>Pagliara</surname> <given-names>D</given-names>
</name>
<name>
<surname>Girardi</surname> <given-names>K</given-names>
</name>
<name>
<surname>Carta</surname> <given-names>R</given-names>
</name>
<name>
<surname>Mastronuzzi</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Canonical and noncanonical roles of fanconi anemia proteins: Implications in cancer predisposition</article-title>. <source>Cancers</source>. (<year>2020</year>) <volume>12</volume>:<fpage>2684</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cancers12092684</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeong</surname> <given-names>E</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>S-G</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>H-S</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Shin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Structural basis of the fanconi anemia-associated mutations within the FANCA and FANCG complex</article-title>. <source>Nucleic Acids Res</source>. (<year>2020</year>) <volume>48</volume>:<page-range>3328&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkaa062</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Ko</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>YJ</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hasty</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>The phenotype of FancB-mutant mouse embryonic stem cells</article-title>. <source>Mutat Res/Fundamental Mol Mech Mutagenesis</source>. (<year>2011</year>) <volume>712</volume>:<page-range>20&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mrfmmm.2011.03.010</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noll</surname> <given-names>M</given-names>
</name>
<name>
<surname>Battaile</surname> <given-names>KP</given-names>
</name>
<name>
<surname>Bateman</surname> <given-names>R</given-names>
</name>
<name>
<surname>Lax</surname> <given-names>TP</given-names>
</name>
<name>
<surname>Rathbun</surname> <given-names>K</given-names>
</name>
<name>
<surname>Reifsteck</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex</article-title>. <source>Exp Hematol</source>. (<year>2002</year>) <volume>30</volume>:<page-range>679&#x2013;88</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0301-472X(02)00838-X</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Godthelp</surname> <given-names>BC</given-names>
</name>
<name>
<surname>van Buul</surname> <given-names>PP</given-names>
</name>
<name>
<surname>Jaspers</surname> <given-names>NG</given-names>
</name>
<name>
<surname>Elghalbzouri-Maghrani</surname> <given-names>E</given-names>
</name>
<name>
<surname>van Duijn-Goedhart</surname> <given-names>A</given-names>
</name>
<name>
<surname>Arwert</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2</article-title>. <source>Mutat Res/Fundamental Mol Mech Mutagenesis</source>. (<year>2006</year>) <volume>601</volume>:<fpage>191</fpage>&#x2013;<lpage>201</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mrfmmm.2006.07.003</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walden</surname> <given-names>H</given-names>
</name>
<name>
<surname>Deans</surname> <given-names>AJ</given-names>
</name>
</person-group>. <article-title>The Fanconi anemia DNA repair pathway: structural and functional insights into a complex disorder</article-title>. <source>Annu Rev Biophys</source>. (<year>2014</year>) <volume>43</volume>:<page-range>257&#x2013;78</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-biophys-051013-022737</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gordon</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Alon</surname> <given-names>N</given-names>
</name>
<name>
<surname>Buchwald</surname> <given-names>M</given-names>
</name>
<name>
<surname>FANCC</surname> <given-names>FANCE</given-names>
</name>
</person-group>. <article-title>and FANCD2 form a ternary complex essential to the integrity of the Fanconi anemia DNA damage response pathway</article-title>. <source>J Biol Chem</source>. (<year>2005</year>) <volume>280</volume>:<page-range>36118&#x2013;25</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M507758200</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Auerbach</surname> <given-names>AD</given-names>
</name>
<name>
<surname>Greenbaum</surname> <given-names>J</given-names>
</name>
<name>
<surname>Pujara</surname> <given-names>K</given-names>
</name>
<name>
<surname>Batish</surname> <given-names>SD</given-names>
</name>
<name>
<surname>Bitencourt</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Kokemohr</surname> <given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>Spectrum of sequence variation in the FANCG gene: an International Fanconi Anemia Registry (IFAR) study</article-title>. <source>Hum Mutat</source>. (<year>2003</year>) <volume>21</volume>:<page-range>158&#x2013;68</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/(ISSN)1098-1004</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nath</surname> <given-names>S</given-names>
</name>
<name>
<surname>Somyajit</surname> <given-names>K</given-names>
</name>
<name>
<surname>Mishra</surname> <given-names>A</given-names>
</name>
<name>
<surname>Scully</surname> <given-names>R</given-names>
</name>
<name>
<surname>Nagaraju</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>FANCJ helicase controls the balance between short-and long-tract gene conversions between sister chromatids</article-title>. <source>Nucleic Acids Res</source>. (<year>2017</year>) <volume>45</volume>:<page-range>8886&#x2013;900</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkx586</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frost</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Mazloumi Aboukheili</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Toth</surname> <given-names>R</given-names>
</name>
<name>
<surname>Walden</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Characterization of FANCL variants observed in patient cancer cells</article-title>. <source>Biosci Rep</source>. (<year>2020</year>) <volume>40</volume>:<fpage>BSR20191304</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/BSR20191304</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Domingues-Silva</surname> <given-names>B</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>B</given-names>
</name>
<name>
<surname>Azzalin</surname> <given-names>CM</given-names>
</name>
</person-group>. <article-title>ALTernative functions for human FANCM at telomeres</article-title>. <source>Front Mol Biosci</source>. (<year>2019</year>) <volume>6</volume>:<elocation-id>84</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmolb.2019.00084</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moynahan</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Jasin</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis</article-title>. <source>Nat Rev Mol Cell Biol</source>. (<year>2010</year>) <volume>11</volume>:<fpage>196</fpage>&#x2013;<lpage>207</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrm2851</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>Z-Y</given-names>
</name>
<name>
<surname>Loignon</surname> <given-names>M</given-names>
</name>
<name>
<surname>Han</surname> <given-names>F-Y</given-names>
</name>
<name>
<surname>Panasci</surname> <given-names>L</given-names>
</name>
<name>
<surname>Aloyz</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Xrcc3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase checkpoint activation, and reduced apoptosis</article-title>. <source>J Pharmacol Exp Ther</source>. (<year>2005</year>) <volume>314</volume>:<fpage>495</fpage>&#x2013;<lpage>505</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1124/jpet.105.084053</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lachaud</surname> <given-names>C</given-names>
</name>
<name>
<surname>Castor</surname> <given-names>D</given-names>
</name>
<name>
<surname>Hain</surname> <given-names>K</given-names>
</name>
<name>
<surname>Munoz</surname> <given-names>I</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>J</given-names>
</name>
<name>
<surname>MacArtney</surname> <given-names>TJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Distinct functional roles for the two SLX4 ubiquitin-binding UBZ domains mutated in Fanconi anemia</article-title>. <source>J Cell Sci</source>. (<year>2014</year>) <volume>127</volume>:<page-range>2811&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1242/jcs.146167</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Silva</surname> <given-names>IU</given-names>
</name>
<name>
<surname>McHugh</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Clingen</surname> <given-names>PH</given-names>
</name>
<name>
<surname>Hartley</surname> <given-names>JA</given-names>
</name>
</person-group>. <article-title>Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells</article-title>. <source>Mol Cell Biol</source>. (<year>2000</year>) <volume>20</volume>:<page-range>7980&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/.20.21.7980-7990.2000</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deh&#xe9;</surname> <given-names>P-M</given-names>
</name>
<name>
<surname>Gaillard</surname> <given-names>P-HL</given-names>
</name>
</person-group>. <article-title>Control of structure-specific endonucleases to maintain genome stability</article-title>. <source>Nat Rev Mol Cell Biol</source>. (<year>2017</year>) <volume>18</volume>:<page-range>315&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrm.2016.177</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bunting</surname> <given-names>SF</given-names>
</name>
<name>
<surname>Call&#xe9;n</surname> <given-names>E</given-names>
</name>
<name>
<surname>Kozak</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>N</given-names>
</name>
<name>
<surname>L&#xf3;pez-Contreras</surname> <given-names>AJ</given-names>
</name>
<etal/>
</person-group>. <article-title>BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair</article-title>. <source>Mol Cell</source>. (<year>2012</year>) <volume>46</volume>:<page-range>125&#x2013;35</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molcel.2012.02.015</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greenhough</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>C-C</given-names>
</name>
<name>
<surname>Belan</surname> <given-names>O</given-names>
</name>
<name>
<surname>Kunzelmann</surname> <given-names>S</given-names>
</name>
<name>
<surname>Maslen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Rodrigo-Brenni</surname> <given-names>MC</given-names>
</name>
<etal/>
</person-group>. <article-title>Structure and function of the RAD51B&#x2013;RAD51C&#x2013;RAD51D&#x2013;XRCC2 tumour suppressor</article-title>. <source>Nature</source>. (<year>2023</year>) <volume>619</volume>:<fpage>1</fpage>&#x2013;<lpage>8</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41586-023-06179-1</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mamrak</surname> <given-names>NE</given-names>
</name>
<name>
<surname>Shimamura</surname> <given-names>A</given-names>
</name>
<name>
<surname>Howlett</surname> <given-names>NG</given-names>
</name>
</person-group>. <article-title>Recent discoveries in the molecular pathogenesis of the inherited bone marrow failure syndrome Fanconi anemia</article-title>. <source>Blood Rev</source>. (<year>2017</year>) <volume>31</volume>:<page-range>93&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.blre.2016.10.002</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elia</surname> <given-names>AE</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>DC</given-names>
</name>
<name>
<surname>Willis</surname> <given-names>NA</given-names>
</name>
<name>
<surname>Boardman</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Hajdu</surname> <given-names>I</given-names>
</name>
<name>
<surname>Adeyemi</surname> <given-names>RO</given-names>
</name>
<etal/>
</person-group>. <article-title>RFWD3-dependent ubiquitination of RPA regulates repair at stalled replication forks</article-title>. <source>Mol Cell</source>. (<year>2015</year>) <volume>60</volume>:<page-range>280&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molcel.2015.09.011</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zou</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Preferential localization of hyperphosphorylated replication protein A to double-strand break repair and checkpoint complexes upon DNA damage</article-title>. <source>Biochem J</source>. (<year>2005</year>) <volume>391</volume>:<page-range>473&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/BJ20050379</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deans</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>West</surname> <given-names>SC</given-names>
</name>
</person-group>. <article-title>FANCM connects the genome instability disorders Bloom's Syndrome and Fanconi Anemia</article-title>. <source>Mol Cell</source>. (<year>2009</year>) <volume>36</volume>:<page-range>943&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molcel.2009.12.006</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwab</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Blackford</surname> <given-names>AN</given-names>
</name>
<name>
<surname>Niedzwiedz</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>ATR activation and replication fork restart are defective in FANCM-deficient cells</article-title>. <source>EMBO J</source>. (<year>2010</year>) <volume>29</volume>:<page-range>806&#x2013;18</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/emboj.2009.385</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rohleder</surname> <given-names>F</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Xue</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kuper</surname> <given-names>J</given-names>
</name>
<name>
<surname>Round</surname> <given-names>A</given-names>
</name>
<name>
<surname>Seidman</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>FANCM interacts with PCNA to promote replication traverse of DNA interstrand crosslinks</article-title>. <source>Nucleic Acids Res</source>. (<year>2016</year>) <volume>44</volume>:<page-range>3219&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkw037</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ciccia</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ling</surname> <given-names>C</given-names>
</name>
<name>
<surname>Coulthard</surname> <given-names>R</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Xue</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Meetei</surname> <given-names>AR</given-names>
</name>
<etal/>
</person-group>. <article-title>Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM</article-title>. <source>Mol Cell</source>. (<year>2007</year>) <volume>25</volume>:<page-range>331&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molcel.2007.01.003</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meetei</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Sechi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wallisch</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Young</surname> <given-names>MK</given-names>
</name>
<name>
<surname>Joenje</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome</article-title>. <source>Mol Cell Biol</source>. (<year>2003</year>) <volume>23</volume>:<page-range>3417&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/MCB.23.10.3417-3426.2003</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>H</given-names>
</name>
<name>
<surname>Hussain</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>X</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>A homozygous FANCM frameshift pathogenic variant causes male infertility</article-title>. <source>Genet Med</source>. (<year>2019</year>) <volume>21</volume>:<fpage>62</fpage>&#x2013;<lpage>70</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41436-018-0015-7</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Alon</surname> <given-names>N</given-names>
</name>
<name>
<surname>Mckerlie</surname> <given-names>C</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Meyn</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Buchwald</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Targeted disruption of exons 1 to 6 of the Fanconi Anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia</article-title>. <source>Hum Mol Genet</source>. (<year>2003</year>) <volume>12</volume>:<page-range>2063&#x2013;76</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/hmg/ddg219</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia-Higuera</surname> <given-names>I</given-names>
</name>
<name>
<surname>Kuang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Denham</surname> <given-names>J</given-names>
</name>
<name>
<surname>D'Andrea</surname> <given-names>AD</given-names>
</name>
</person-group>. <article-title>The Fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex</article-title>. <source>Blood J Am Soc Hematol</source>. (<year>2000</year>) <volume>96</volume>:<page-range>3224&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood.V96.9.3224.h8003224_3224_3230</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benitez</surname> <given-names>A</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Palovcak</surname> <given-names>A</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>G</given-names>
</name>
<name>
<surname>Moon</surname> <given-names>J</given-names>
</name>
<name>
<surname>An</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>FANCA promotes DNA double-strand break repair by catalyzing single-strand annealing and strand exchange</article-title>. <source>Mol Cell</source>. (<year>2018</year>) <volume>71</volume>:<fpage>621</fpage>&#x2013;<lpage>628. e4</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molcel.2018.06.030</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jarysta</surname> <given-names>A</given-names>
</name>
<name>
<surname>Riou</surname> <given-names>L</given-names>
</name>
<name>
<surname>Firlej</surname> <given-names>V</given-names>
</name>
<name>
<surname>Lapoujade</surname> <given-names>C</given-names>
</name>
<name>
<surname>Kortulewski</surname> <given-names>T</given-names>
</name>
<name>
<surname>Barroca</surname> <given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Abnormal migration behavior linked to Rac1 signaling contributes to primordial germ cell exhaustion in Fanconi anemia pathway-deficient Fancg&#x2013;/&#x2013; embryos</article-title>. <source>Hum Mol Genet</source>. (<year>2022</year>) <volume>31</volume>:<fpage>97</fpage>&#x2013;<lpage>110</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/hmg/ddab222</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Alavattam</surname> <given-names>KG</given-names>
</name>
<name>
<surname>Sin</surname> <given-names>H-S</given-names>
</name>
<name>
<surname>Meetei</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Pang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Andreassen</surname> <given-names>PR</given-names>
</name>
<etal/>
</person-group>. <article-title>FANCB is essential in the male germline and regulates H3K9 methylation on the sex chromosomes during meiosis</article-title>. <source>Hum Mol Genet</source>. (<year>2015</year>) <volume>24</volume>:<page-range>5234&#x2013;49</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/hmg/ddv244</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jamsai</surname> <given-names>D</given-names>
</name>
<name>
<surname>O&#x2019;Connor</surname> <given-names>AE</given-names>
</name>
<name>
<surname>O&#x2019;Donnell</surname> <given-names>L</given-names>
</name>
<name>
<surname>Lo</surname> <given-names>JCY</given-names>
</name>
<name>
<surname>O&#x2019;Bryan</surname> <given-names>MK</given-names>
</name>
</person-group>. <article-title>Uncoupling of transcription and translation of Fanconi anemia (FANC) complex proteins during spermatogenesis</article-title>. <source>Spermatogenesis</source>. (<year>2015</year>) <volume>5</volume>:<elocation-id>e979061</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.4161/21565562.2014.979061</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nadler</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Braun</surname> <given-names>RE</given-names>
</name>
</person-group>. <article-title>Fanconi anemia complementation group C is required for proliferation of murine primordial germ cells</article-title>. <source>genesis</source>. (<year>2000</year>) <volume>27</volume>:<page-range>117&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/(ISSN)1526-968X</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taniguchi</surname> <given-names>T</given-names>
</name>
<name>
<surname>D'Andrea</surname> <given-names>AD</given-names>
</name>
</person-group>. <article-title>The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC</article-title>. <source>Blood J Am Soc Hematol</source>. (<year>2002</year>) <volume>100</volume>:<page-range>2457&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2002-03-0860</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taniguchi</surname> <given-names>T</given-names>
</name>
<name>
<surname>Garcia-Higuera</surname> <given-names>I</given-names>
</name>
<name>
<surname>Andreassen</surname> <given-names>PR</given-names>
</name>
<name>
<surname>Gregory</surname> <given-names>RC</given-names>
</name>
<name>
<surname>Grompe</surname> <given-names>M</given-names>
</name>
<name>
<surname>D'Andrea</surname> <given-names>AD</given-names>
</name>
</person-group>. <article-title>S-phase&#x2013;specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51</article-title>. <source>Blood J Am Soc Hematol</source>. (<year>2002</year>) <volume>100</volume>:<page-range>2414&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2002-01-0278</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Begum</surname> <given-names>K</given-names>
</name>
<name>
<surname>Jordan</surname> <given-names>PW</given-names>
</name>
<name>
<surname>He</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Overbeek</surname> <given-names>PA</given-names>
</name>
</person-group>. <article-title>Dearth and delayed maturation of testicular germ cells in Fanconi anemia E mutant male mice</article-title>. <source>PloS One</source>. (<year>2016</year>) <volume>11</volume>:<elocation-id>e0159800</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0159800</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pace</surname> <given-names>P</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>M</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>WM</given-names>
</name>
<name>
<surname>Mosedale</surname> <given-names>G</given-names>
</name>
<name>
<surname>Sng</surname> <given-names>C</given-names>
</name>
<name>
<surname>Hoatlin</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>FANCE: the link between Fanconi anaemia complex assembly and activity</article-title>. <source>EMBO J</source>. (<year>2002</year>) <volume>21</volume>:<page-range>3414&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/emboj/cdf355</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>L&#xe9;veill&#xe9;</surname> <given-names>F</given-names>
</name>
<name>
<surname>Blom</surname> <given-names>E</given-names>
</name>
<name>
<surname>Medhurst</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Bier</surname> <given-names>P</given-names>
</name>
<name>
<surname>Laghmani</surname> <given-names>EH</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>The Fanconi anemia gene product FANCF is a flexible adaptor protein</article-title>. <source>J Biol Chem</source>. (<year>2004</year>) <volume>279</volume>:<page-range>39421&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M407034200</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Youssoufian</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells</article-title>. <source>Proc Natl Acad Sci</source>. (<year>1994</year>) <volume>91</volume>:<page-range>7975&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.91.17.7975</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>L&#xe9;veill&#xe9;</surname> <given-names>F</given-names>
</name>
<name>
<surname>Ferrer</surname> <given-names>M</given-names>
</name>
<name>
<surname>Medhurst</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Laghmani</surname> <given-names>EH</given-names>
</name>
<name>
<surname>Rooimans</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Bier</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>The nuclear accumulation of the Fanconi anemia protein FANCE depends on FANCC</article-title>. <source>DNA Repair</source>. (<year>2006</year>) <volume>5</volume>:<page-range>556&#x2013;65</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.dnarep.2006.01.005</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bouffard</surname> <given-names>F</given-names>
</name>
<name>
<surname>Plourde</surname> <given-names>K</given-names>
</name>
<name>
<surname>B&#xe9;langer</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ouellette</surname> <given-names>G</given-names>
</name>
<name>
<surname>Labrie</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Durocher</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Analysis of a FANCE splice isoform in regard to DNA repair</article-title>. <source>J Mol Biol</source>. (<year>2015</year>) <volume>427</volume>:<page-range>3056&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jmb.2015.08.004</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Winter</surname> <given-names>JP</given-names>
</name>
<name>
<surname>van der Weel</surname> <given-names>L</given-names>
</name>
<name>
<surname>De Groot</surname> <given-names>J</given-names>
</name>
<name>
<surname>Stone</surname> <given-names>S</given-names>
</name>
<name>
<surname>Waisfisz</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Arwert</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG</article-title>. <source>Hum Mol Genet</source>. (<year>2000</year>) <volume>9</volume>:<page-range>2665&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/hmg/9.18.2665</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bakker</surname> <given-names>ST</given-names>
</name>
<name>
<surname>van de Vrugt</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Visser</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Delzenne-Goette</surname> <given-names>E</given-names>
</name>
<name>
<surname>Wal</surname> <given-names>Avd</given-names>
</name>
<name>
<surname>Berns</surname> <given-names>MA</given-names>
</name>
<etal/>
</person-group>. <article-title>Fancf-deficient mice are prone to develop ovarian tumours</article-title>. <source>J Pathol</source>. (<year>2012</year>) <volume>226</volume>:<fpage>28</fpage>&#x2013;<lpage>39</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/path.2992</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname> <given-names>DK</given-names>
</name>
<name>
<surname>Gamboa</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Walkemeier</surname> <given-names>B</given-names>
</name>
<name>
<surname>Van Leene</surname> <given-names>J</given-names>
</name>
<name>
<surname>De Jaeger</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>The FANCC&#x2013;FANCE&#x2013;FANCF complex is evolutionarily conserved and regulates meiotic recombination</article-title>. <source>Nucleic Acids Res</source>. (<year>2023</year>) <volume>51</volume>:<page-range>2516&#x2013;28</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkac1244</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cornwell</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Thomson</surname> <given-names>GJ</given-names>
</name>
<name>
<surname>Coates</surname> <given-names>J</given-names>
</name>
<name>
<surname>Belotserkovskaya</surname> <given-names>R</given-names>
</name>
<name>
<surname>Waddell</surname> <given-names>ID</given-names>
</name>
<name>
<surname>Jackson</surname> <given-names>SP</given-names>
</name>
<etal/>
</person-group>. <article-title>Small-molecule inhibition of UBE2T/FANCL-mediated ubiquitylation in the Fanconi anemia pathway</article-title>. <source>ACS Chem Biol</source>. (<year>2019</year>) <volume>14</volume>:<page-range>2148&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/acschembio.9b00570</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>S</given-names>
</name>
<name>
<surname>Li</surname> <given-names>G</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>UBE2T resolves transcription-replication conflicts and protects common fragile sites in primordial germ cells</article-title>. <source>Cell Mol Life Sci</source>. (<year>2023</year>) <volume>80</volume>:<fpage>92</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00018-023-04733-8</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dubois</surname> <given-names>EL</given-names>
</name>
<name>
<surname>Guitton-Sert</surname> <given-names>L</given-names>
</name>
<name>
<surname>B&#xe9;liveau</surname> <given-names>M</given-names>
</name>
<name>
<surname>Parmar</surname> <given-names>K</given-names>
</name>
<name>
<surname>Chagraoui</surname> <given-names>J</given-names>
</name>
<name>
<surname>Vignard</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>and distinct functions for FANCI and FANCD2</article-title>. <source>Nucleic Acids Res</source>. (<year>2019</year>) <volume>47</volume>:<page-range>7532&#x2013;47</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkz514</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname> <given-names>W</given-names>
</name>
<name>
<surname>van Twest</surname> <given-names>S</given-names>
</name>
<name>
<surname>Leis</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bythell-Douglas</surname> <given-names>R</given-names>
</name>
<name>
<surname>Murphy</surname> <given-names>VJ</given-names>
</name>
<name>
<surname>Sharp</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Monoubiquitination by the human Fanconi anemia core complex clamps FANCI: FANCD2 on DNA in filamentous arrays</article-title>. <source>elife</source>. (<year>2020</year>) <volume>9</volume>:<fpage>e54128</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.54128</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>S</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>DNA repair protein FANCD2 has both ubiquitination-dependent and ubiquitination-independent functions during germ cell development</article-title>. <source>J Biol Chem</source>. (<year>2023</year>) <volume>299</volume>:<fpage>102905</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jbc.2023.102905</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al Jabri</surname> <given-names>A</given-names>
</name>
<name>
<surname>Al Naim</surname> <given-names>N</given-names>
</name>
<name>
<surname>Al Dossari</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Homozygous mutation in the FANCD2 gene observed in a Saudi male infant with severe ambiguous genitalia</article-title>. <source>Case Rep Endocrinol</source>. (<year>2021</year>) <volume>2021</volume>:<fpage>6686312</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2021/6686312</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoogenboom</surname> <given-names>WS</given-names>
</name>
<name>
<surname>Boonen</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Knipscheer</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>The role of SLX4 and its associated nucleases in DNA interstrand crosslink repair</article-title>. <source>Nucleic Acids Res</source>. (<year>2019</year>) <volume>47</volume>:<page-range>2377&#x2013;88</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gky1276</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>D</given-names>
</name>
<name>
<surname>Xiong</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>SLX4IP acts with SLX4 and XPF&#x2013;ERCC1 to promote interstrand crosslink repair</article-title>. <source>Nucleic Acids Res</source>. (<year>2019</year>) <volume>47</volume>:<page-range>10181&#x2013;201</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkz769</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Douwel</surname> <given-names>DK</given-names>
</name>
<name>
<surname>Boonen</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Long</surname> <given-names>DT</given-names>
</name>
<name>
<surname>Szypowska</surname> <given-names>AA</given-names>
</name>
<name>
<surname>R&#xe4;schle</surname> <given-names>M</given-names>
</name>
<name>
<surname>Walter</surname> <given-names>JC</given-names>
</name>
<etal/>
</person-group>. <article-title>XPF-ERCC1 acts in Unhooking DNA interstrand crosslinks in cooperation with FANCD2 and FANCP/SLX4</article-title>. <source>Mol Cell</source>. (<year>2014</year>) <volume>54</volume>:<page-range>460&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molcel.2014.03.015</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crossan</surname> <given-names>GP</given-names>
</name>
<name>
<surname>Patel</surname> <given-names>KJ</given-names>
</name>
</person-group>. <article-title>The Fanconi anaemia pathway orchestrates incisions at sites of crosslinked DNA</article-title>. <source>J Pathol</source>. (<year>2012</year>) <volume>226</volume>:<page-range>326&#x2013;37</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/path.3002</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bogliolo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Schuster</surname> <given-names>B</given-names>
</name>
<name>
<surname>Stoepker</surname> <given-names>C</given-names>
</name>
<name>
<surname>Derkunt</surname> <given-names>B</given-names>
</name>
<name>
<surname>Su</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Raams</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia</article-title>. <source>Am J Hum Genet</source>. (<year>2013</year>) <volume>92</volume>:<page-range>800&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ajhg.2013.04.002</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mar&#xed;n</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ram&#xed;rez</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Aza Carmona</surname> <given-names>M</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>N</given-names>
</name>
<name>
<surname>Ogi</surname> <given-names>T</given-names>
</name>
<name>
<surname>Bogliolo</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Functional comparison of XPF missense mutations associated to multiple DNA repair disorders</article-title>. <source>Genes</source>. (<year>2019</year>) <volume>10</volume>:<fpage>60</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/genes10010060</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guiraldelli</surname> <given-names>MF</given-names>
</name>
<name>
<surname>Felberg</surname> <given-names>A</given-names>
</name>
<name>
<surname>Almeida</surname> <given-names>LP</given-names>
</name>
<name>
<surname>Parikh</surname> <given-names>A</given-names>
</name>
<name>
<surname>de Castro</surname> <given-names>RO</given-names>
</name>
<name>
<surname>Pezza</surname> <given-names>RJ</given-names>
</name>
</person-group>. <article-title>SHOC1 is a ERCC4-(HhH) 2-like protein, integral to the formation of crossover recombination intermediates during mammalian meiosis</article-title>. <source>PloS Genet</source>. (<year>2018</year>) <volume>14</volume>:<elocation-id>e1007381</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pgen.1007381</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>L</given-names>
</name>
<name>
<surname>He</surname> <given-names>J</given-names>
</name>
<name>
<surname>Su</surname> <given-names>L</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Bi-allelic variants in SHOC1 cause non-obstructive azoospermia with meiosis arrest in humans and mice</article-title>. <source>Mol Hum Reprod</source>. (<year>2022</year>) <volume>28</volume>:<fpage>gaac015</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/molehr/gaac015</pub-id>
</citation>
</ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bluteau</surname> <given-names>D</given-names>
</name>
<name>
<surname>Masliah-Planchon</surname> <given-names>J</given-names>
</name>
<name>
<surname>Clairmont</surname> <given-names>C</given-names>
</name>
<name>
<surname>Rousseau</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ceccaldi</surname> <given-names>R</given-names>
</name>
<name>
<surname>d&#x2019;Enghien</surname> <given-names>CD</given-names>
</name>
<etal/>
</person-group>. <article-title>Biallelic inactivation of REV7 is associated with Fanconi anemia</article-title>. <source>J Clin Invest</source>. (<year>2016</year>) <volume>126</volume>:<page-range>3580&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI88010</pub-id>
</citation>
</ref>
<ref id="B76">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname> <given-names>S</given-names>
</name>
<name>
<surname>Helchowski</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Canman</surname> <given-names>CE</given-names>
</name>
</person-group>. <article-title>The roles of DNA polymerase &#x3b6; and the Y family DNA polymerases in promoting or preventing genome instability</article-title>. <source>Mutat Res/Fundamental Mol Mech Mutagenesis</source>. (<year>2013</year>) <volume>743</volume>:<fpage>97</fpage>&#x2013;<lpage>110</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mrfmmm.2012.11.002</pub-id>
</citation>
</ref>
<ref id="B77">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>R&#xe4;schle</surname> <given-names>M</given-names>
</name>
<name>
<surname>Knipscheer</surname> <given-names>P</given-names>
</name>
<name>
<surname>Enoiu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Angelov</surname> <given-names>T</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>J</given-names>
</name>
<name>
<surname>Griffith</surname> <given-names>JD</given-names>
</name>
<etal/>
</person-group>. <article-title>Mechanism of replication-coupled DNA interstrand crosslink repair</article-title>. <source>Cell</source>. (<year>2008</year>) <volume>134</volume>:<page-range>969&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2008.08.030</pub-id>
</citation>
</ref>
<ref id="B78">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hara</surname> <given-names>K</given-names>
</name>
<name>
<surname>Shimizu</surname> <given-names>T</given-names>
</name>
<name>
<surname>Unzai</surname> <given-names>S</given-names>
</name>
<name>
<surname>Akashi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sato</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hashimoto</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Purification, crystallization and initial X-ray diffraction study of human REV7 in complex with a REV3 fragment</article-title>. <source>Acta Crystallographica Section F: Struct Biol Crystallization Commun</source>. (<year>2009</year>) <volume>65</volume>:<page-range>1302&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1107/S1744309109046181</pub-id>
</citation>
</ref>
<ref id="B79">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe</surname> <given-names>N</given-names>
</name>
<name>
<surname>Mii</surname> <given-names>S</given-names>
</name>
<name>
<surname>Asai</surname> <given-names>N</given-names>
</name>
<name>
<surname>Asai</surname> <given-names>M</given-names>
</name>
<name>
<surname>Niimi</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ushida</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>The REV7 subunit of DNA polymerase &#x3b6; is essential for primordial germ cell maintenance in the mouse</article-title>. <source>J Biol Chem</source>. (<year>2013</year>) <volume>288</volume>:<page-range>10459&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M112.421966</pub-id>
</citation>
</ref>
<ref id="B80">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tomida</surname> <given-names>J</given-names>
</name>
<name>
<surname>K.-i. Takata</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Schibler</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Yousefzadeh</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Bhetawal</surname> <given-names>S</given-names>
</name>
<name>
<surname>Dent</surname> <given-names>SY</given-names>
</name>
<etal/>
</person-group>. <article-title>REV7 is essential for DNA damage tolerance <italic>via</italic> two REV3L binding sites in mammalian DNA polymerase &#x3b6;</article-title>. <source>Nucleic Acids Res</source>. (<year>2015</year>) <volume>43</volume>:<page-range>1000&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gku1385</pub-id>
</citation>
</ref>
<ref id="B81">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simhadri</surname> <given-names>S</given-names>
</name>
<name>
<surname>Peterson</surname> <given-names>S</given-names>
</name>
<name>
<surname>Patel</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Huo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>H</given-names>
</name>
<name>
<surname>Bowman-Colin</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Male fertility defect associated with disrupted BRCA1-PALB2 interaction in mice</article-title>. <source>J Biol Chem</source>. (<year>2014</year>) <volume>289</volume>:<page-range>24617&#x2013;29</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M114.566141</pub-id>
</citation>
</ref>
<ref id="B82">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>K</given-names>
</name>
<name>
<surname>Andreassen</surname> <given-names>PR</given-names>
</name>
</person-group>. <article-title>PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2</article-title>. <source>Mol Cancer Res</source>. (<year>2009</year>) <volume>7</volume>:<page-range>1110&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/1541-7786.MCR-09-0123</pub-id>
</citation>
</ref>
<ref id="B83">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sy</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Huen</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>PALB2 is an integral component of the BRCA complex required for homologous recombination repair</article-title>. <source>Proc Natl Acad Sci</source>. (<year>2009</year>) <volume>106</volume>:<page-range>7155&#x2013;60</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0811159106</pub-id>
</citation>
</ref>
<ref id="B84">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>L</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>H</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>PALB2 links BRCA1 and BRCA2 in the DNA-damage response</article-title>. <source>Curr Biol</source>. (<year>2009</year>) <volume>19</volume>:<page-range>524&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cub.2009.02.018</pub-id>
</citation>
</ref>
<ref id="B85">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sy</surname> <given-names>SM-H</given-names>
</name>
<name>
<surname>Huen</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>PALB2 regulates recombinational repair through chromatin association and oligomerization</article-title>. <source>J Biol Chem</source>. (<year>2009</year>) <volume>284</volume>:<page-range>18302&#x2013;10</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M109.016717</pub-id>
</citation>
</ref>
<ref id="B86">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Aprelikova</surname> <given-names>O</given-names>
</name>
<name>
<surname>Moens</surname> <given-names>P</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>C-X</given-names>
</name>
<name>
<surname>Furth</surname> <given-names>PA</given-names>
</name>
</person-group>. <article-title>Impaired meiotic DNA-damage repair and lack of crossing-over during spermatogenesis in BRCA1 full-length isoform deficient mice</article-title>. <source>Development</source>. (<year>2003</year>) <volume>130</volume>:<page-range>2001&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1242/dev.00410</pub-id>
</citation>
</ref>
<ref id="B87">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gallina</surname> <given-names>I</given-names>
</name>
<name>
<surname>Hendriks</surname> <given-names>IA</given-names>
</name>
<name>
<surname>Hoffmann</surname> <given-names>S</given-names>
</name>
<name>
<surname>Larsen</surname> <given-names>NB</given-names>
</name>
<name>
<surname>Johansen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Colding-Christensen</surname> <given-names>CS</given-names>
</name>
<etal/>
</person-group>. <article-title>The ubiquitin ligase RFWD3 is required for translesion DNA synthesis</article-title>. <source>Mol Cell</source>. (<year>2021</year>) <volume>81</volume>:<page-range>442&#x2013;58</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molcel.2020.11.029</pub-id>
</citation>
</ref>
<ref id="B88">
<label>88</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodr&#xed;guez-Mar&#xed;</surname> <given-names>A</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>C</given-names>
</name>
<name>
<surname>Titus</surname> <given-names>TA</given-names>
</name>
<name>
<surname>Canestro</surname> <given-names>C</given-names>
</name>
<name>
<surname>BreMiller</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>Y-L</given-names>
</name>
<etal/>
</person-group>. <article-title>Roles of brca2 (fancd1) in oocyte nuclear architecture, gametogenesis, gonad tumors, and genome stability in zebrafish</article-title>. <source>PloS Genet</source>. (<year>2011</year>) <volume>7</volume>:<elocation-id>e1001357</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pgen.1001357</pub-id>
</citation>
</ref>
<ref id="B89">
<label>89</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhoucun</surname> <given-names>A</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>The common variant N372H in BRCA2 gene may be associated with idiopathic male infertility with azoospermia or severe oligozoospermia</article-title>. <source>Eur J Obstet Gynecol Reprod Biol</source>. (<year>2006</year>) <volume>124</volume>:<page-range>61&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejogrb.2005.09.001</pub-id>
</citation>
</ref>
<ref id="B90">
<label>90</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramanagoudr-Bhojappa</surname> <given-names>R</given-names>
</name>
<name>
<surname>Carrington</surname> <given-names>B</given-names>
</name>
<name>
<surname>Ramaswami</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bishop</surname> <given-names>K</given-names>
</name>
<name>
<surname>Robbins</surname> <given-names>GM</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Multiplexed CRISPR/Cas9-mediated knockout of 19 Fanconi anemia pathway genes in zebrafish revealed their roles in growth, sexual development and fertility</article-title>. <source>PloS Genet</source>. (<year>2018</year>) <volume>14</volume>:<elocation-id>e1007821</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pgen.1007821</pub-id>
</citation>
</ref>
<ref id="B91">
<label>91</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>N</given-names>
</name>
<name>
<surname>Schild</surname> <given-names>D</given-names>
</name>
<name>
<surname>Thelen</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>LH</given-names>
</name>
</person-group>. <article-title>Involvement of Rad51C in two distinct protein complexes of Rad51 paralogs in human cells</article-title>. <source>Nucleic Acids Res</source>. (<year>2002</year>) <volume>30</volume>:<page-range>1009&#x2013;15</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/30.4.1009</pub-id>
</citation>
</ref>
<ref id="B92">
<label>92</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname> <given-names>H</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Copenhaver</surname> <given-names>GP</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>RAD51C and XRCC3 proteins form a complex and facilitate RAD51 localization on chromosomes for meiotic recombination</article-title>. <source>PloS Genet</source>. (<year>2017</year>) <volume>13</volume>:<elocation-id>e1006827</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pgen.1006827</pub-id>
</citation>
</ref>
<ref id="B93">
<label>93</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Somyajit</surname> <given-names>K</given-names>
</name>
<name>
<surname>Subramanya</surname> <given-names>S</given-names>
</name>
<name>
<surname>Nagaraju</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair</article-title>. <source>J Biol Chem</source>. (<year>2012</year>) <volume>287</volume>:<page-range>3366&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M111.311241</pub-id>
</citation>
</ref>
<ref id="B94">
<label>94</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuznetsov</surname> <given-names>S</given-names>
</name>
<name>
<surname>Pellegrini</surname> <given-names>M</given-names>
</name>
<name>
<surname>Shuda</surname> <given-names>K</given-names>
</name>
<name>
<surname>Fernandez-Capetillo</surname> <given-names>O</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>BK</given-names>
</name>
<etal/>
</person-group>. <article-title>RAD51C deficiency in mice results in early prophase I arrest in males and sister chromatid separation at metaphase II in females</article-title>. <source>J Cell Biol</source>. (<year>2007</year>) <volume>176</volume>:<page-range>581&#x2013;92</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1083/jcb.200608130</pub-id>
</citation>
</ref>
<ref id="B95">
<label>95</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>J</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>XRCC2 mutation causes meiotic arrest, azoospermia and infertility</article-title>. <source>J Med Genet</source>. (<year>2018</year>) <volume>55</volume>:<page-range>628&#x2013;36</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/jmedgenet-2017-105145</pub-id>
</citation>
</ref>
<ref id="B96">
<label>96</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>J-Y</given-names>
</name>
<name>
<surname>Virts</surname> <given-names>EL</given-names>
</name>
<name>
<surname>Jankowska</surname> <given-names>A</given-names>
</name>
<name>
<surname>Wiek</surname> <given-names>C</given-names>
</name>
<name>
<surname>Othman</surname> <given-names>M</given-names>
</name>
<name>
<surname>Chakraborty</surname> <given-names>SC</given-names>
</name>
<etal/>
</person-group>. <article-title>Complementation of hypersensitivity to DNA interstrand crosslinking agents demonstrates that XRCC2 is a Fanconi anaemia gene</article-title>. <source>J Med Genet</source>. (<year>2016</year>) <volume>53</volume>:<page-range>672&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/jmedgenet-2016-103847</pub-id>
</citation>
</ref>
<ref id="B97">
<label>97</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Somyajit</surname> <given-names>K</given-names>
</name>
<name>
<surname>Saxena</surname> <given-names>S</given-names>
</name>
<name>
<surname>Babu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Mishra</surname> <given-names>A</given-names>
</name>
<name>
<surname>Nagaraju</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Mammalian RAD51 paralogs protect nascent DNA at stalled forks and mediate replication restart</article-title>. <source>Nucleic Acids Res</source>. (<year>2015</year>) <volume>43</volume>:<page-range>9835&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkv880</pub-id>
</citation>
</ref>
<ref id="B98">
<label>98</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Branzei</surname> <given-names>D</given-names>
</name>
<name>
<surname>Foiani</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Maintaining genome stability at the replication fork</article-title>. <source>Nat Rev Mol Cell Biol</source>. (<year>2010</year>) <volume>11</volume>:<page-range>208&#x2013;19</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrm2852</pub-id>
</citation>
</ref>
<ref id="B99">
<label>99</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takata</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sasaki</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Tachiiri</surname> <given-names>S</given-names>
</name>
<name>
<surname>Fukushima</surname> <given-names>T</given-names>
</name>
<name>
<surname>Sonoda</surname> <given-names>E</given-names>
</name>
<name>
<surname>Schild</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs</article-title>. <source>Mol Cell Biol</source>. (<year>2001</year>) <volume>21</volume>:<page-range>2858&#x2013;66</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/MCB.21.8.2858-2866.2001</pub-id>
</citation>
</ref>
<ref id="B100">
<label>100</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knies</surname> <given-names>K</given-names>
</name>
<name>
<surname>Inano</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ram&#xed;rez</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Ishiai</surname> <given-names>M</given-names>
</name>
<name>
<surname>Surrall&#xe9;s</surname> <given-names>J</given-names>
</name>
<name>
<surname>Takata</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia</article-title>. <source>J Clin Invest</source>. (<year>2017</year>) <volume>127</volume>:<page-range>3013&#x2013;27</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI92069</pub-id>
</citation>
</ref>
<ref id="B101">
<label>101</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moore</surname> <given-names>CE</given-names>
</name>
<name>
<surname>Yalcindag</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Czeladko</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ravindranathan</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wijesekara Hanthi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Levy</surname> <given-names>JC</given-names>
</name>
<etal/>
</person-group>. <article-title>RFWD3 promotes ZRANB3 recruitment to regulate the remodeling of stalled replication forks</article-title>. <source>J Cell Biol</source>. (<year>2023</year>) <volume>222</volume>:<elocation-id>e202106022</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1083/jcb.202106022</pub-id>
</citation>
</ref>
<ref id="B102">
<label>102</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Chu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yucer</surname> <given-names>N</given-names>
</name>
<name>
<surname>Leng</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S-Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>BP</given-names>
</name>
<etal/>
</person-group>. <article-title>RING finger and WD repeat domain 3 (RFWD3) associates with replication protein A (RPA) and facilitates RPA-mediated DNA damage response</article-title>. <source>J Biol Chem</source>. (<year>2011</year>) <volume>286</volume>:<page-range>22314&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M111.222802</pub-id>
</citation>
</ref>
<ref id="B103">
<label>103</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gong</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>E3 ligase RFWD3 participates in replication checkpoint control</article-title>. <source>J Biol Chem</source>. (<year>2011</year>) <volume>286</volume>:<page-range>22308&#x2013;13</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M111.222869</pub-id>
</citation>
</ref>
<ref id="B104">
<label>104</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cimprich</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Cortez</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>ATR: an essential regulator of genome integrity</article-title>. <source>Nat Rev Mol Cell Biol</source>. (<year>2008</year>) <volume>9</volume>:<page-range>616&#x2013;27</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrm2450</pub-id>
</citation>
</ref>
<ref id="B105">
<label>105</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feeney</surname> <given-names>L</given-names>
</name>
<name>
<surname>Munoz</surname> <given-names>IM</given-names>
</name>
<name>
<surname>Lachaud</surname> <given-names>C</given-names>
</name>
<name>
<surname>Toth</surname> <given-names>R</given-names>
</name>
<name>
<surname>Appleton</surname> <given-names>PL</given-names>
</name>
<name>
<surname>Schindler</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>RPA-mediated recruitment of the E3 ligase RFWD3 is vital for interstrand crosslink repair and human health</article-title>. <source>Mol Cell</source>. (<year>2017</year>) <volume>66</volume>:<page-range>610&#x2013;21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molcel.2017.04.021</pub-id>
</citation>
</ref>
<ref id="B106">
<label>106</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inano</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sato</surname> <given-names>K</given-names>
</name>
<name>
<surname>Katsuki</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kobayashi</surname> <given-names>W</given-names>
</name>
<name>
<surname>Tanaka</surname> <given-names>H</given-names>
</name>
<name>
<surname>Nakajima</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>RFWD3-mediated ubiquitination promotes timely removal of both RPA and RAD51 from DNA damage sites to facilitate homologous recombination</article-title>. <source>Mol Cell</source>. (<year>2017</year>) <volume>66</volume>:<fpage>622</fpage>&#x2013;<lpage>634. e8</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molcel.2017.04.022</pub-id>
</citation>
</ref>
<ref id="B107">
<label>107</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>X</given-names>
</name>
<name>
<surname>Brie&#xf1;o-Enr&#xed;quez</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Cornelius</surname> <given-names>A</given-names>
</name>
<name>
<surname>Modzelewski</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Maley</surname> <given-names>TT</given-names>
</name>
<name>
<surname>Campbell-Peterson</surname> <given-names>KM</given-names>
</name>
<etal/>
</person-group>. <article-title>FancJ (Brip1) loss-of-function allele results in spermatogonial cell depletion during embryogenesis and altered processing of crossover sites during meiotic prophase I in mice</article-title>. <source>Chromosoma</source>. (<year>2016</year>) <volume>125</volume>:<page-range>237&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00412-015-0549-2</pub-id>
</citation>
</ref>
<ref id="B108">
<label>108</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calvo</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Fritchman</surname> <given-names>B</given-names>
</name>
<name>
<surname>Hernandez</surname> <given-names>D</given-names>
</name>
<name>
<surname>Persky</surname> <given-names>NS</given-names>
</name>
<name>
<surname>Johannessen</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Piccioni</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Comprehensive mutational analysis of the BRCA1-associated DNA helicase and tumor-suppressor FANCJ/BACH1/BRIP1</article-title>. <source>Mol Cancer Res</source>. (<year>2021</year>) <volume>19</volume>:<page-range>1015&#x2013;25</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/1541-7786.MCR-20-0828</pub-id>
</citation>
</ref>
<ref id="B109">
<label>109</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brosh</surname> <given-names>RM</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Cantor</surname> <given-names>SB</given-names>
</name>
</person-group>. <article-title>Molecular and cellular functions of the FANCJ DNA helicase defective in cancer and in Fanconi anemia</article-title>. <source>Front Genet</source>. (<year>2014</year>) <volume>5</volume>:<elocation-id>372</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fgene.2014.00372</pub-id>
</citation>
</ref>
<ref id="B110">
<label>110</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Joenje</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Fanconi anemia and DNA replication repair</article-title>. <source>DNA Repair</source>. (<year>2007</year>) <volume>6</volume>:<page-range>885&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.dnarep.2007.02.002</pub-id>
</citation>
</ref>
<ref id="B111">
<label>111</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joo</surname> <given-names>W</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>G</given-names>
</name>
<name>
<surname>Persky</surname> <given-names>NS</given-names>
</name>
<name>
<surname>Smogorzewska</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rudge</surname> <given-names>DG</given-names>
</name>
<name>
<surname>Buzovetsky</surname> <given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>Structure of the FANCI-FANCD2 complex: insights into the Fanconi anemia DNA repair pathway</article-title>. <source>Science</source>. (<year>2011</year>) <volume>333</volume>:<page-range>312&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1205805</pub-id>
</citation>
</ref>
<ref id="B112">
<label>112</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaugule</surname> <given-names>VK</given-names>
</name>
<name>
<surname>Arkinson</surname> <given-names>C</given-names>
</name>
<name>
<surname>Rennie</surname> <given-names>ML</given-names>
</name>
<name>
<surname>K&#xe4;m&#xe4;r&#xe4;inen</surname> <given-names>O</given-names>
</name>
<name>
<surname>Toth</surname> <given-names>R</given-names>
</name>
<name>
<surname>Walden</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Allosteric mechanism for site-specific ubiquitination of FANCD2</article-title>. <source>Nat Chem Biol</source>. (<year>2020</year>) <volume>16</volume>:<fpage>291</fpage>&#x2013;<lpage>301</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41589-019-0426-z</pub-id>
</citation>
</ref>
<ref id="B113">
<label>113</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alpi</surname> <given-names>AF</given-names>
</name>
<name>
<surname>Chaugule</surname> <given-names>V</given-names>
</name>
<name>
<surname>Walden</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Mechanism and disease association of E2-conjugating enzymes: lessons from UBE2T and UBE2L3</article-title>. <source>Biochem J</source>. (<year>2016</year>) <volume>473</volume>:<page-range>3401&#x2013;19</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/BCJ20160028</pub-id>
</citation>
</ref>
<ref id="B114">
<label>114</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lachaud</surname> <given-names>C</given-names>
</name>
<name>
<surname>Moreno</surname> <given-names>A</given-names>
</name>
<name>
<surname>Marchesi</surname> <given-names>F</given-names>
</name>
<name>
<surname>Toth</surname> <given-names>R</given-names>
</name>
<name>
<surname>Blow</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Rouse</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Ubiquitinated Fancd2 recruits Fan1 to stalled replication forks to prevent genome instability</article-title>. <source>Science</source>. (<year>2016</year>) <volume>351</volume>:<page-range>846&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.aad5634</pub-id>
</citation>
</ref>
<ref id="B115">
<label>115</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murina</surname> <given-names>O</given-names>
</name>
<name>
<surname>von Aesch</surname> <given-names>C</given-names>
</name>
<name>
<surname>Karakus</surname> <given-names>U</given-names>
</name>
<name>
<surname>Ferretti</surname> <given-names>LP</given-names>
</name>
<name>
<surname>Bolck</surname> <given-names>HA</given-names>
</name>
<name>
<surname>H&#xe4;nggi</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>FANCD2 and CtIP cooperate to repair DNA interstrand crosslinks</article-title>. <source>Cell Rep</source>. (<year>2014</year>) <volume>7</volume>:<page-range>1030&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.celrep.2014.03.069</pub-id>
</citation>
</ref>
<ref id="B116">
<label>116</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Siu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Bezabeh</surname> <given-names>T</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Focal point of Fanconi anemia signaling</article-title>. <source>Int J Mol Sci</source>. (<year>2021</year>) <volume>22</volume>:<fpage>12976</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms222312976</pub-id>
</citation>
</ref>
<ref id="B117">
<label>117</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lefferts</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Sridharan</surname> <given-names>D</given-names>
</name>
<name>
<surname>Baralt</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lambert</surname> <given-names>MW</given-names>
</name>
</person-group>. <article-title>The SH3 domain of &#x3b1;II spectrin is a target for the Fanconi anemia protein, FANCG</article-title>. <source>Biochemistry</source>. (<year>2009</year>) <volume>48</volume>:<page-range>254&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/bi801483u</pub-id>
</citation>
</ref>
<ref id="B118">
<label>118</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kuang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>De Oca</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Hays</surname> <given-names>T</given-names>
</name>
<name>
<surname>Moreau</surname> <given-names>L</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9</article-title>. <source>Blood J Am Soc Hematol</source>. (<year>2001</year>) <volume>98</volume>:<page-range>3435&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood.V98.12.3435</pub-id>
</citation>
</ref>
<ref id="B119">
<label>119</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hassani Moghaddam</surname> <given-names>M</given-names>
</name>
<name>
<surname>Eskandari</surname> <given-names>N</given-names>
</name>
<name>
<surname>Nikzad</surname> <given-names>H</given-names>
</name>
<name>
<surname>Miryounesi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Karimian</surname> <given-names>M</given-names>
</name>
<name>
<surname>Amini Mahabadi</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Primordial germ cells can be differentiated by retinoic acid and progesterone induction from embryonic stem cells</article-title>. <source>J Biosci</source>. (<year>2021</year>) <volume>46</volume>:<fpage>1</fpage>&#x2013;<lpage>10</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12038-021-00210-1</pub-id>
</citation>
</ref>
<ref id="B120">
<label>120</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Landelouci</surname> <given-names>K</given-names>
</name>
<name>
<surname>Sinha</surname> <given-names>S</given-names>
</name>
<name>
<surname>P&#xe9;pin</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Type-I interferon signaling in fanconi anemia</article-title>. <source>Front Cell Infect Microbiol</source>. (<year>2022</year>) <volume>12</volume>:<elocation-id>820273</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.820273</pub-id>
</citation>
</ref>
<ref id="B121">
<label>121</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ablasser</surname> <given-names>A</given-names>
</name>
<name>
<surname>Goldeck</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cavlar</surname> <given-names>T</given-names>
</name>
<name>
<surname>Deimling</surname> <given-names>T</given-names>
</name>
<name>
<surname>Witte</surname> <given-names>G</given-names>
</name>
<name>
<surname>R&#xf6;hl</surname> <given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>cGAS produces a 2&#x2032;-5&#x2032;-linked cyclic dinucleotide second messenger that activates STING</article-title>. <source>Nature</source>. (<year>2013</year>) <volume>498</volume>:<page-range>380&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature12306</pub-id>
</citation>
</ref>
<ref id="B122">
<label>122</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kermi</surname> <given-names>C</given-names>
</name>
<name>
<surname>Lo Furno</surname> <given-names>E</given-names>
</name>
<name>
<surname>Maiorano</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Regulation of DNA replication in early embryonic cleavages</article-title>. <source>Genes</source>. (<year>2017</year>) <volume>8</volume>:<fpage>42</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/genes8010042</pub-id>
</citation>
</ref>
<ref id="B123">
<label>123</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mutreja</surname> <given-names>K</given-names>
</name>
<name>
<surname>Krietsch</surname> <given-names>J</given-names>
</name>
<name>
<surname>Hess</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ursich</surname> <given-names>S</given-names>
</name>
<name>
<surname>Berti</surname> <given-names>M</given-names>
</name>
<name>
<surname>Roessler</surname> <given-names>FK</given-names>
</name>
<etal/>
</person-group>. <article-title>ATR-mediated global fork slowing and reversal assist fork traverse and prevent chromosomal breakage at DNA interstrand cross-links</article-title>. <source>Cell Rep</source>. (<year>2018</year>) <volume>24</volume>:<fpage>2629</fpage>&#x2013;<lpage>2642. e5</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.celrep.2018.08.019</pub-id>
</citation>
</ref>
<ref id="B124">
<label>124</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopez-Martinez</surname> <given-names>D</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>C-C</given-names>
</name>
<name>
<surname>Cohn</surname> <given-names>MA</given-names>
</name>
</person-group>. <article-title>Cellular response to DNA interstrand crosslinks: the Fanconi anemia pathway</article-title>. <source>Cell Mol Life Sci</source>. (<year>2016</year>) <volume>73</volume>:<page-range>3097&#x2013;114</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00018-016-2218-x</pub-id>
</citation>
</ref>
<ref id="B125">
<label>125</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chesner</surname> <given-names>LN</given-names>
</name>
<name>
<surname>Degner</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sangaraju</surname> <given-names>D</given-names>
</name>
<name>
<surname>Yomtoubian</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wickramaratne</surname> <given-names>S</given-names>
</name>
<name>
<surname>Malayappan</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Cellular repair of DNA&#x2013;DNA cross-links induced by 1, 2, 3, 4-diepoxybutane</article-title>. <source>Int J Mol Sci</source>. (<year>2017</year>) <volume>18</volume>:<fpage>1086</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms18051086</pub-id>
</citation>
</ref>
<ref id="B126">
<label>126</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>P</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>N</given-names>
</name>
<name>
<surname>Jing</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ji</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Novel bi-allelic variants of FANCM cause sertoli cell-only syndrome and non-obstructive azoospermia</article-title>. <source>Front Genet</source>. (<year>2021</year>) <volume>12</volume>:<elocation-id>799886</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fgene.2021.799886</pub-id>
</citation>
</ref>
<ref id="B127">
<label>127</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kherraf</surname> <given-names>Z-E</given-names>
</name>
<name>
<surname>Cazin</surname> <given-names>C</given-names>
</name>
<name>
<surname>Bouker</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mustapha</surname> <given-names>SFB</given-names>
</name>
<name>
<surname>Hennebicq</surname> <given-names>S</given-names>
</name>
<name>
<surname>Septier</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Whole-exome sequencing improves the diagnosis and care of men with non-obstructive azoospermia</article-title>. <source>Am J Hum Genet</source>. (<year>2022</year>) <volume>109</volume>:<page-range>508&#x2013;17</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ajhg.2022.01.011</pub-id>
</citation>
</ref>
<ref id="B128">
<label>128</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cant&#xfa;</surname> <given-names>AV</given-names>
</name>
<name>
<surname>Laird</surname> <given-names>DJ</given-names>
</name>
</person-group>. <article-title>A pilgrim's progress: Seeking meaning in primordial germ cell migration</article-title>. <source>Stem Cell Res</source>. (<year>2017</year>) <volume>24</volume>:<page-range>181&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.scr.2017.07.017</pub-id>
</citation>
</ref>
<ref id="B129">
<label>129</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kasak</surname> <given-names>L</given-names>
</name>
<name>
<surname>Punab</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nagirnaja</surname> <given-names>L</given-names>
</name>
<name>
<surname>Grigorova</surname> <given-names>M</given-names>
</name>
<name>
<surname>Minajeva</surname> <given-names>A</given-names>
</name>
<name>
<surname>Lopes</surname> <given-names>AM</given-names>
</name>
<etal/>
</person-group>. <article-title>Bi-allelic recessive loss-of-function variants in FANCM cause non-obstructive azoospermia</article-title>. <source>Am J Hum Genet</source>. (<year>2018</year>) <volume>103</volume>:<page-range>200&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ajhg.2018.07.005</pub-id>
</citation>
</ref>
<ref id="B130">
<label>130</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van De Vrugt</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>NC</given-names>
</name>
<name>
<surname>De Vries</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Rooimans</surname> <given-names>MA</given-names>
</name>
<name>
<surname>De Groot</surname> <given-names>J</given-names>
</name>
<name>
<surname>Scheper</surname> <given-names>RJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Cloning and characterization of murine fanconi anemia group A gene: Fanca protein is expressed in lymphoid tissues, testis, and ovary</article-title>. <source>Mamm Genome</source>. (<year>2000</year>) <volume>11</volume>:<page-range>326&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s003350010060</pub-id>
</citation>
</ref>
<ref id="B131">
<label>131</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Li</surname> <given-names>K</given-names>
</name>
<name>
<surname>Geng</surname> <given-names>H</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Lv</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Identification of deleterious variants in patients with male infertility due to idiopathic non-obstructive azoospermia</article-title>. <source>Reprod Biol Endocrinol</source>. (<year>2022</year>) <volume>20</volume>:<fpage>63</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12958-022-00936-z</pub-id>
</citation>
</ref>
<ref id="B132">
<label>132</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van de Vrugt</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Koomen</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bakker</surname> <given-names>S</given-names>
</name>
<name>
<surname>Berns</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>NC</given-names>
</name>
<name>
<surname>van der Valk</surname> <given-names>MA</given-names>
</name>
<etal/>
</person-group>. <article-title>Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg</article-title>. <source>DNA Repair</source>. (<year>2011</year>) <volume>10</volume>:<page-range>1252&#x2013;61</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.dnarep.2011.09.015</pub-id>
</citation>
</ref>
<ref id="B133">
<label>133</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heinrich</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Silvey</surname> <given-names>KV</given-names>
</name>
<name>
<surname>Stone</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zigler</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Griffith</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Montalto</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Posttranscriptional cell cycle&#x2013;dependent regulation of human FANCC expression</article-title>. <source>Blood J Am Soc Hematol</source>. (<year>2000</year>) <volume>95</volume>:<page-range>3970&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood.V95.12.3970</pub-id>
</citation>
</ref>
<ref id="B134">
<label>134</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Odroniec</surname> <given-names>A</given-names>
</name>
<name>
<surname>Olszewska</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kurpisz</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Epigenetic markers in the embryonal germ cell development and spermatogenesis</article-title>. <source>Basic Clin Androl</source>. (<year>2023</year>) <volume>33</volume>:<fpage>6</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12610-022-00179-3</pub-id>
</citation>
</ref>
<ref id="B135">
<label>135</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tournaye</surname> <given-names>H</given-names>
</name>
<name>
<surname>Krausz</surname> <given-names>C</given-names>
</name>
<name>
<surname>Oates</surname> <given-names>RD</given-names>
</name>
</person-group>. <article-title>Novel concepts in the aetiology of male reproductive impairment</article-title>. <source>Lancet Diabetes Endocrinol</source>. (<year>2017</year>) <volume>5</volume>:<page-range>544&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S2213-8587(16)30040-7</pub-id>
</citation>
</ref>
<ref id="B136">
<label>136</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>KH</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>P</given-names>
</name>
<name>
<surname>Park</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>SJ</given-names>
</name>
<etal/>
</person-group>. <article-title>MAST4 controls cell cycle in spermatogonial stem cells</article-title>. <source>Cell Prolif</source>. (<year>2023</year>) <volume>56</volume>:<elocation-id>e13390</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cpr.13390</pub-id>
</citation>
</ref>
<ref id="B137">
<label>137</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koul</surname> <given-names>S</given-names>
</name>
<name>
<surname>McKiernan</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Narayan</surname> <given-names>G</given-names>
</name>
<name>
<surname>Houldsworth</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bacik</surname> <given-names>J</given-names>
</name>
<name>
<surname>Dobrzynski</surname> <given-names>DL</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors</article-title>. <source>Mol Cancer</source>. (<year>2004</year>) <volume>3</volume>:<fpage>1</fpage>&#x2013;<lpage>12</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1476-4598-3-16</pub-id>
</citation>
</ref>
<ref id="B138">
<label>138</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>F</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Su</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Study of spermatogenic and Sertoli cells in the Hu sheep testes at different developmental stages</article-title>. <source>FASEB J</source>. (<year>2023</year>) <volume>37</volume>:<elocation-id>e23084</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1096/fj.202300373R</pub-id>
</citation>
</ref>
<ref id="B139">
<label>139</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yun</surname> <given-names>D</given-names>
</name>
<name>
<surname>Sang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>L</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Defects of microtubule cytoskeletal organization in NOA human testes</article-title>. <source>Reprod Biol Endocrinol</source>. (<year>2022</year>) <volume>20</volume>:<fpage>1</fpage>&#x2013;<lpage>17</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12958-022-01026-w</pub-id>
</citation>
</ref>
<ref id="B140">
<label>140</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname> <given-names>DK</given-names>
</name>
<name>
<surname>Gamboa</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Walkemeier</surname> <given-names>B</given-names>
</name>
<name>
<surname>Van Leene</surname> <given-names>J</given-names>
</name>
<name>
<surname>De Jaeger</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>NAR Breakthrough Article The FANCC&#x2013;FANCE&#x2013;FANCF complex is evolutionarily</article-title>. <source>Nucleic Acids Res</source>. (<year>2023</year>) <volume>51</volume>:<fpage>2517</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkac1244</pub-id>
</citation>
</ref>
<ref id="B141">
<label>141</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>D'Andrea</surname> <given-names>AD</given-names>
</name>
<name>
<surname>Grompe</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>The Fanconi anaemia/BRCA pathway</article-title>. <source>Nat Rev Cancer</source>. (<year>2003</year>) <volume>3</volume>:<fpage>23</fpage>&#x2013;<lpage>34</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrc970</pub-id>
</citation>
</ref>
<ref id="B142">
<label>142</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Machida</surname> <given-names>YJ</given-names>
</name>
<name>
<surname>Machida</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Gurtan</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Kupfer</surname> <given-names>GM</given-names>
</name>
<name>
<surname>D'Andrea</surname> <given-names>AD</given-names>
</name>
<etal/>
</person-group>. <article-title>UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation</article-title>. <source>Mol Cell</source>. (<year>2006</year>) <volume>23</volume>:<page-range>589&#x2013;96</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molcel.2006.06.024</pub-id>
</citation>
</ref>
<ref id="B143">
<label>143</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Li</surname> <given-names>D</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>F</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>FANCI plays an essential role in spermatogenesis and regulates meiotic histone methylation</article-title>. <source>Cell Death Dis</source>. (<year>2021</year>) <volume>12</volume>:<fpage>780</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41419-021-04096-7</pub-id>
</citation>
</ref>
<ref id="B144">
<label>144</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nepal</surname> <given-names>M</given-names>
</name>
<name>
<surname>Che</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Fei</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>FANCD2 and DNA damage</article-title>. <source>Int J Mol Sci</source>. (<year>2017</year>) <volume>18</volume>:<fpage>1804</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms18081804</pub-id>
</citation>
</ref>
<ref id="B145">
<label>145</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Bosques</surname> <given-names>L</given-names>
</name>
<name>
<surname>Sung</surname> <given-names>P</given-names>
</name>
<name>
<surname>Kupfer</surname> <given-names>GM</given-names>
</name>
</person-group>. <article-title>A novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage</article-title>. <source>Oncogene</source>. (<year>2016</year>) <volume>35</volume>:<fpage>22</fpage>&#x2013;<lpage>34</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/onc.2015.68</pub-id>
</citation>
</ref>
<ref id="B146">
<label>146</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sondalle</surname> <given-names>SB</given-names>
</name>
<name>
<surname>Longerich</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ogawa</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Sung</surname> <given-names>P</given-names>
</name>
<name>
<surname>Baserga</surname> <given-names>SJ</given-names>
</name>
</person-group>. <article-title>Fanconi anemia protein FANCI functions in ribosome biogenesis</article-title>. <source>Proc Natl Acad Sci</source>. (<year>2019</year>) <volume>116</volume>:<page-range>2561&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1811557116</pub-id>
</citation>
</ref>
<ref id="B147">
<label>147</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>UBE2T regulates FANCI monoubiquitination to promote NSCLC progression by activating EMT</article-title>. <source>Oncol Rep</source>. (<year>2022</year>) <volume>48</volume>:<fpage>1</fpage>&#x2013;<lpage>13</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/or</pub-id>
</citation>
</ref>
<ref id="B148">
<label>148</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lemonidis</surname> <given-names>K</given-names>
</name>
<name>
<surname>Arkinson</surname> <given-names>C</given-names>
</name>
<name>
<surname>Rennie</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Walden</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Mechanism, specificity, and function of FANCD2-FANCI ubiquitination and deubiquitination</article-title>. <source>FEBS J</source>. (<year>2022</year>) <volume>289</volume>:<page-range>4811&#x2013;29</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/febs.16077</pub-id>
</citation>
</ref>
<ref id="B149">
<label>149</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rickman</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Lach</surname> <given-names>FP</given-names>
</name>
<name>
<surname>Abhyankar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Donovan</surname> <given-names>FX</given-names>
</name>
<name>
<surname>Sanborn</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Kennedy</surname> <given-names>JA</given-names>
</name>
<etal/>
</person-group>. <article-title>Deficiency of UBE2T, the E2 ubiquitin ligase necessary for FANCD2 and FANCI ubiquitination, causes FA-T subtype of Fanconi anemia</article-title>. <source>Cell Rep</source>. (<year>2015</year>) <volume>12</volume>:<fpage>35</fpage>&#x2013;<lpage>41</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.celrep.2015.06.014</pub-id>
</citation>
</ref>
<ref id="B150">
<label>150</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname> <given-names>W</given-names>
</name>
<name>
<surname>Van Twest</surname> <given-names>S</given-names>
</name>
<name>
<surname>Murphy</surname> <given-names>VJ</given-names>
</name>
<name>
<surname>Deans</surname> <given-names>AJ</given-names>
</name>
</person-group>. <article-title>ATR-mediated FANCI phosphorylation regulates both ubiquitination and deubiquitination of FANCD2</article-title>. <source>Front Cell Dev Biol</source>. (<year>2020</year>) <volume>8</volume>:<elocation-id>2</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcell.2020.00002</pub-id>
</citation>
</ref>
<ref id="B151">
<label>151</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Parmar</surname> <given-names>K</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Weinstock</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Ruit</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Kutok</surname> <given-names>JL</given-names>
</name>
<etal/>
</person-group>. <article-title>Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype</article-title>. <source>Dev Cell</source>. (<year>2009</year>) <volume>16</volume>:<page-range>314&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.devcel.2009.01.001</pub-id>
</citation>
</ref>
<ref id="B152">
<label>152</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arafat</surname> <given-names>M</given-names>
</name>
<name>
<surname>Har-Vardi</surname> <given-names>I</given-names>
</name>
<name>
<surname>Harlev</surname> <given-names>A</given-names>
</name>
<name>
<surname>Levitas</surname> <given-names>E</given-names>
</name>
<name>
<surname>Zeadna</surname> <given-names>A</given-names>
</name>
<name>
<surname>Abofoul-Azab</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Mutation in TDRD9 causes non-obstructive azoospermia in infertile men</article-title>. <source>J Med Genet</source>. (<year>2017</year>) <volume>54</volume>:<page-range>633&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/jmedgenet-2017-104514</pub-id>
</citation>
</ref>
<ref id="B153">
<label>153</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alavattam</surname> <given-names>KG</given-names>
</name>
<name>
<surname>Kato</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Sin</surname> <given-names>H-S</given-names>
</name>
<name>
<surname>Maezawa</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kowalski</surname> <given-names>IJ</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Elucidation of the Fanconi anemia protein network in meiosis and its function in the regulation of histone modifications</article-title>. <source>Cell Rep</source>. (<year>2016</year>) <volume>17</volume>:<page-range>1141&#x2013;57</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.celrep.2016.09.073</pub-id>
</citation>
</ref>
<ref id="B154">
<label>154</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>F</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Y chromosome haplogroups based genome-wide association study pinpoints revelation for interactions on non-obstructive azoospermia</article-title>. <source>Sci Rep</source>. (<year>2016</year>) <volume>6</volume>:<fpage>33363</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/srep33363</pub-id>
</citation>
</ref>
<ref id="B155">
<label>155</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>N</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>L</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>MicroRNA expression profiles in the seminal plasma of nonobstructive azoospermia patients with different histopathologic patterns</article-title>. <source>Fertil Steril</source>. (<year>2021</year>) <volume>115</volume>:<page-range>1197&#x2013;211</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fertnstert.2020.11.020</pub-id>
</citation>
</ref>
<ref id="B156">
<label>156</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osorio</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bogliolo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fern&#xe1;ndez</surname> <given-names>V</given-names>
</name>
<name>
<surname>Barroso</surname> <given-names>A</given-names>
</name>
<name>
<surname>de la Hoya</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cald&#xe9;s</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Evaluation of rare variants in the new F anconi anemia gene ERCC 4 (FANCQ) as familial breast/ovarian cancer susceptibility alleles</article-title>. <source>Hum Mutat</source>. (<year>2013</year>) <volume>34</volume>:<page-range>1615&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/humu.22438</pub-id>
</citation>
</ref>
<ref id="B157">
<label>157</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghieh</surname> <given-names>F</given-names>
</name>
<name>
<surname>Barbotin</surname> <given-names>A</given-names>
</name>
<name>
<surname>Swierkowski-Blanchard</surname> <given-names>N</given-names>
</name>
<name>
<surname>Leroy</surname> <given-names>C</given-names>
</name>
<name>
<surname>Fortemps</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gerault</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Whole-exome sequencing in patients with maturation arrest: a potential additional diagnostic tool for prevention of recurrent negative testicular sperm extraction outcomes</article-title>. <source>Hum Reprod</source>. (<year>2022</year>) <volume>37</volume>:<page-range>1334&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/humrep/deac057</pub-id>
</citation>
</ref>
<ref id="B158">
<label>158</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakurai</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ichinoe</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yoshida</surname> <given-names>K</given-names>
</name>
<name>
<surname>Nakazato</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Saito</surname> <given-names>S</given-names>
</name>
<name>
<surname>Satoh</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Inactivation of REV7 enhances chemosensitivity and overcomes acquired chemoresistance in testicular germ cell tumors</article-title>. <source>Cancer Lett</source>. (<year>2020</year>) <volume>489</volume>:<page-range>100&#x2013;10</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.canlet.2020.06.001</pub-id>
</citation>
</ref>
<ref id="B159">
<label>159</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huselid</surname> <given-names>E</given-names>
</name>
<name>
<surname>Bunting</surname> <given-names>SF</given-names>
</name>
</person-group>. <article-title>The regulation of homologous recombination by helicases</article-title>. <source>Genes</source>. (<year>2020</year>) <volume>11</volume>:<fpage>498</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/genes11050498</pub-id>
</citation>
</ref>
<ref id="B160">
<label>160</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhingra</surname> <given-names>N</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Intricate SUMO-based control of the homologous recombination machinery</article-title>. <source>Genes Dev</source>. (<year>2019</year>) <volume>33</volume>:<page-range>1346&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/gad.328534.119</pub-id>
</citation>
</ref>
<ref id="B161">
<label>161</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ali</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Pradhan</surname> <given-names>A</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>TR</given-names>
</name>
<name>
<surname>Du</surname> <given-names>C</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wahengbam</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>FAAP20: a novel ubiquitin-binding FA nuclear core-complex protein required for functional integrity of the FA-BRCA DNA repair pathway</article-title>. <source>Blood J Am Soc Hematol</source>. (<year>2012</year>) <volume>119</volume>:<page-range>3285&#x2013;94</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2011-10-385963</pub-id>
</citation>
</ref>
<ref id="B162">
<label>162</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michl</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zimmer</surname> <given-names>J</given-names>
</name>
<name>
<surname>Tarsounas</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Interplay between Fanconi anemia and homologous recombination pathways in genome integrity</article-title>. <source>EMBO J</source>. (<year>2016</year>) <volume>35</volume>:<page-range>909&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.15252/embj.201693860</pub-id>
</citation>
</ref>
<ref id="B163">
<label>163</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le</surname> <given-names>W</given-names>
</name>
<name>
<surname>Qi</surname> <given-names>L</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Xiang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Mao</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Preliminary study of the homologous recombination repair pathway in mouse spermatogonial stem cells</article-title>. <source>Andrology</source>. (<year>2018</year>) <volume>6</volume>:<page-range>488&#x2013;97</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/andr.12481</pub-id>
</citation>
</ref>
<ref id="B164">
<label>164</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahlskog</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Larsen</surname> <given-names>BD</given-names>
</name>
<name>
<surname>Achanta</surname> <given-names>K</given-names>
</name>
<name>
<surname>S&#xf8;rensen</surname> <given-names>CS</given-names>
</name>
</person-group>. <article-title>ATM/ATR-mediated phosphorylation of PALB 2 promotes RAD 51 function</article-title>. <source>EMBO Rep</source>. (<year>2016</year>) <volume>17</volume>:<page-range>671&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.15252/embr.201541455</pub-id>
</citation>
</ref>
<ref id="B165">
<label>165</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>W</given-names>
</name>
<name>
<surname>Sy</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Huen</surname> <given-names>MS</given-names>
</name>
</person-group>. <article-title>ATM-dependent phosphorylation of the Fanconi anemia protein PALB2 promotes the DNA damage response</article-title>. <source>J Biol Chem</source>. (<year>2015</year>) <volume>290</volume>:<page-range>27545&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M115.672626</pub-id>
</citation>
</ref>
<ref id="B166">
<label>166</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jensen</surname> <given-names>CFS</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Mamsen</surname> <given-names>LS</given-names>
</name>
<name>
<surname>Giwercman</surname> <given-names>A</given-names>
</name>
<name>
<surname>J&#xf8;rgensen</surname> <given-names>N</given-names>
</name>
<name>
<surname>Fode</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Sertoli and germ cells within atrophic seminiferous tubules of men with non-obstructive azoospermia</article-title>. <source>Front Endocrinol</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>825904</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2022.825904</pub-id>
</citation>
</ref>
<ref id="B167">
<label>167</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sawyer</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>L</given-names>
</name>
<name>
<surname>K&#xe4;hk&#xf6;nen</surname> <given-names>M</given-names>
</name>
<name>
<surname>Schwartzentruber</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kircher</surname> <given-names>M</given-names>
</name>
<collab>U.o.W.C.f.M. Genomics, F.C. Consortium</collab>
<etal/>
</person-group>. <article-title>Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype</article-title>. <source>Cancer Discovery</source>. (<year>2015</year>) <volume>5</volume>:<page-range>135&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/2159-8290.CD-14-1156</pub-id>
</citation>
</ref>
<ref id="B168">
<label>168</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Qi</surname> <given-names>L</given-names>
</name>
<name>
<surname>Chiang</surname> <given-names>H-C</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>B</given-names>
</name>
<name>
<surname>Li</surname> <given-names>R</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>BRCA1 antibodies matter</article-title>. <source>Int J Biol Sci</source>. (<year>2021</year>) <volume>17</volume>:<fpage>3239</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7150/ijbs.63115</pub-id>
</citation>
</ref>
<ref id="B169">
<label>169</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation</article-title>. <source>Cancer Cell</source>. (<year>2013</year>) <volume>23</volume>:<fpage>693</fpage>&#x2013;<lpage>704</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ccr.2013.03.025</pub-id>
</citation>
</ref>
<ref id="B170">
<label>170</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname> <given-names>W-H</given-names>
</name>
<name>
<surname>Kusumoto</surname> <given-names>R</given-names>
</name>
<name>
<surname>Opresko</surname> <given-names>PL</given-names>
</name>
<name>
<surname>Sui</surname> <given-names>X</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Nicolette</surname> <given-names>ML</given-names>
</name>
<etal/>
</person-group>. <article-title>Collaboration of Werner syndrome protein and BRCA1 in cellular responses to DNA interstrand cross-links</article-title>. <source>Nucleic Acids Res</source>. (<year>2006</year>) <volume>34</volume>:<page-range>2751&#x2013;60</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkl362</pub-id>
</citation>
</ref>
<ref id="B171">
<label>171</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Durocher</surname> <given-names>F</given-names>
</name>
<name>
<surname>Simard</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ouellette</surname> <given-names>J</given-names>
</name>
<name>
<surname>Richard</surname> <given-names>V</given-names>
</name>
<name>
<surname>Labrie</surname> <given-names>F</given-names>
</name>
<name>
<surname>Pelletier</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Localization of BRCA1 gene expression in adult cynomolgus monkey tissues</article-title>. <source>J Histochem Cytochem</source>. (<year>1997</year>) <volume>45</volume>:<page-range>1173&#x2013;88</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/002215549704500901</pub-id>
</citation>
</ref>
<ref id="B172">
<label>172</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adamczewska</surname> <given-names>D</given-names>
</name>
<name>
<surname>S&#x142;owikowska-Hilczer</surname> <given-names>J</given-names>
</name>
<name>
<surname>Walczak-J&#x119;drzejowska</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>The fate of leydig cells in men with spermatogenic failure</article-title>. <source>Life</source>. (<year>2022</year>) <volume>12</volume>:<fpage>570</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/life12040570</pub-id>
</citation>
</ref>
<ref id="B173">
<label>173</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sciurano</surname> <given-names>RB</given-names>
</name>
<name>
<surname>Rahn</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pigozzi</surname> <given-names>MI</given-names>
</name>
<name>
<surname>Olmedo</surname> <given-names>SB</given-names>
</name>
<name>
<surname>Solari</surname> <given-names>AJ</given-names>
</name>
</person-group>. <article-title>An azoospermic man with a double-strand DNA break-processing deficiency in the spermatocyte nuclei: case report</article-title>. <source>Hum Reprod</source>. (<year>2006</year>) <volume>21</volume>:<page-range>1194&#x2013;203</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/humrep/dei479</pub-id>
</citation>
</ref>
<ref id="B174">
<label>174</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharan</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Pyle</surname> <given-names>A</given-names>
</name>
<name>
<surname>Coppola</surname> <given-names>V</given-names>
</name>
<name>
<surname>Babus</surname> <given-names>J</given-names>
</name>
<name>
<surname>Swaminathan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Benedict</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>BRCA2 deficiency in mice leads to meiotic impairment and infertility</article-title>. <source>Development</source>. (<year>2004</year>) <volume>131</volume>:<page-range>131&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1242/dev.00888</pub-id>
</citation>
</ref>
<ref id="B175">
<label>175</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weinberg-Shukron</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rachmiel</surname> <given-names>M</given-names>
</name>
<name>
<surname>Renbaum</surname> <given-names>P</given-names>
</name>
<name>
<surname>Gulsuner</surname> <given-names>S</given-names>
</name>
<name>
<surname>Walsh</surname> <given-names>T</given-names>
</name>
<name>
<surname>Lobel</surname> <given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>Essential role of BRCA2 in ovarian development and function</article-title>. <source>New Engl J Med</source>. (<year>2018</year>) <volume>379</volume>:<page-range>1042&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1056/NEJMoa1800024</pub-id>
</citation>
</ref>
<ref id="B176">
<label>176</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shive</surname> <given-names>HR</given-names>
</name>
<name>
<surname>West</surname> <given-names>RR</given-names>
</name>
<name>
<surname>Embree</surname> <given-names>LJ</given-names>
</name>
<name>
<surname>Azuma</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sood</surname> <given-names>R</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>brca2 in zebrafish ovarian development, spermatogenesis, and tumorigenesis</article-title>. <source>Proc Natl Acad Sci</source>. (<year>2010</year>) <volume>107</volume>:<page-range>19350&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1011630107</pub-id>
</citation>
</ref>
<ref id="B177">
<label>177</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>St Martin</surname> <given-names>EC</given-names>
</name>
<name>
<surname>Ferrer</surname> <given-names>A</given-names>
</name>
<name>
<surname>Wudhikarn</surname> <given-names>K</given-names>
</name>
<name>
<surname>Mangaonkar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Hogan</surname> <given-names>W</given-names>
</name>
<name>
<surname>Tefferi</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Clinical features and survival outcomes in patients with chronic myelomonocytic leukemia arising in the context of germline predisposition syndromes</article-title>. <source>Am J Hematol</source>. (<year>2021</year>) <volume>96</volume>:<page-range>E327&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ajh.26250</pub-id>
</citation>
</ref>
<ref id="B178">
<label>178</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dosanjh</surname> <given-names>MK</given-names>
</name>
<name>
<surname>Collins</surname> <given-names>DW</given-names>
</name>
<name>
<surname>Schild</surname> <given-names>D</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>W</given-names>
</name>
<name>
<surname>Lennon</surname> <given-names>GG</given-names>
</name>
<name>
<surname>Albala</surname> <given-names>JS</given-names>
</name>
<etal/>
</person-group>. <article-title>Isolation and characterization of RAD51C, a new human member of the RAD51 family of related genes</article-title>. <source>Nucleic Acids Res</source>. (<year>1998</year>) <volume>26</volume>:<page-range>1179&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/26.5.1179</pub-id>
</citation>
</ref>
<ref id="B179">
<label>179</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Badie</surname> <given-names>S</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>C</given-names>
</name>
<name>
<surname>Thanasoula</surname> <given-names>M</given-names>
</name>
<name>
<surname>Barber</surname> <given-names>P</given-names>
</name>
<name>
<surname>Hill</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Tarsounas</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation</article-title>. <source>J Cell Biol</source>. (<year>2009</year>) <volume>185</volume>:<fpage>587</fpage>&#x2013;<lpage>600</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1083/jcb.200811079</pub-id>
</citation>
</ref>
<ref id="B180">
<label>180</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>T</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Dang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>RAD51 is essential for spermatogenesis and male fertility in mice</article-title>. <source>Cell Death Discovery</source>. (<year>2022</year>) <volume>8</volume>:<fpage>118</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41420-022-00921-w</pub-id>
</citation>
</ref>
<ref id="B181">
<label>181</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braybrooke</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Spink</surname> <given-names>KG</given-names>
</name>
<name>
<surname>Thacker</surname> <given-names>J</given-names>
</name>
<name>
<surname>Hickson</surname> <given-names>ID</given-names>
</name>
</person-group>. <article-title>The RAD51 family member, RAD51L3, is a DNA-stimulated ATPase that forms a complex with XRCC2</article-title>. <source>J Biol Chem</source>. (<year>2000</year>) <volume>275</volume>:<page-range>29100&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M002075200</pub-id>
</citation>
</ref>
<ref id="B182">
<label>182</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Y-X</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H-Y</given-names>
</name>
<name>
<surname>He</surname> <given-names>W-B</given-names>
</name>
<name>
<surname>Tu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Du</surname> <given-names>J</given-names>
</name>
<name>
<surname>Li</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>XRCC2 mutation causes premature ovarian insufficiency as well as non-obstructive azoospermia in humans</article-title>. <source>Clin Genet</source>. (<year>2019</year>) <volume>95</volume>:<page-range>442&#x2013;3</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cge.13475</pub-id>
</citation>
</ref>
<ref id="B183">
<label>183</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>D-H</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kanner</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sung</surname> <given-names>P</given-names>
</name>
<name>
<surname>Borowiec</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Chowdhury</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>A PP4 phosphatase complex dephosphorylates RPA2 to facilitate DNA repair <italic>via</italic> homologous recombination</article-title>. <source>Nat Struct Mol Biol</source>. (<year>2010</year>) <volume>17</volume>:<page-range>365&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nsmb.1769</pub-id>
</citation>
</ref>
<ref id="B184">
<label>184</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voutsadakis</surname> <given-names>IA</given-names>
</name>
</person-group>. <article-title>Landscape of BRIP1 molecular lesions in gastrointestinal cancers from published genomic studies</article-title>. <source>World J Gastroenterol</source>. (<year>2020</year>) <volume>26</volume>:<fpage>1197</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3748/wjg.v26.i11.1197</pub-id>
</citation>
</ref>
<ref id="B185">
<label>185</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname> <given-names>M</given-names>
</name>
<name>
<surname>Litman</surname> <given-names>R</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>S</given-names>
</name>
<name>
<surname>Brosh</surname> <given-names>RM</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Cantor</surname> <given-names>SB</given-names>
</name>
</person-group>. <article-title>The FANCJ/MutL&#x3b1; interaction is required for correction of the cross-link response in FA-J cells</article-title>. <source>EMBO J</source>. (<year>2007</year>) <volume>26</volume>:<page-range>3238&#x2013;49</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/sj.emboj.7601754</pub-id>
</citation>
</ref>
<ref id="B186">
<label>186</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kubota</surname> <given-names>H</given-names>
</name>
<name>
<surname>Brinster</surname> <given-names>RL</given-names>
</name>
</person-group>. <article-title>Spermatogonial stem cells</article-title>. <source>Biol Reprod</source>. (<year>2018</year>) <volume>99</volume>:<fpage>52</fpage>&#x2013;<lpage>74</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/biolre/ioy077</pub-id>
</citation>
</ref>
<ref id="B187">
<label>187</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vij</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Sabanegh</surname> <given-names>E</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Agarwal</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Biological therapy for non-obstructive azoospermia</article-title>. <source>Expert Opin Biol Ther</source>. (<year>2018</year>) <volume>18</volume>:<fpage>19</fpage>&#x2013;<lpage>23</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/14712598.2018.1380622</pub-id>
</citation>
</ref>
<ref id="B188">
<label>188</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishikawa</surname> <given-names>T</given-names>
</name>
<name>
<surname>Mizuta</surname> <given-names>S</given-names>
</name>
<name>
<surname>Yamaguchi</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ohara</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Doshida</surname> <given-names>M</given-names>
</name>
<name>
<surname>Takeuchi</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>P-030 Clinical outcomes of microdissection testicular sperm extraction (micro TESE) and intracytoplasmic sperm injection (ICSI) in non-obstructive azoospermia (NOA) with the history of cryptorchidism</article-title>. <source>Hum Reprod</source>. (<year>2023</year>) <volume>38</volume>:<fpage>dead093. 397</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/humrep/dead093.397</pub-id>
</citation>
</ref>
<ref id="B189">
<label>189</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elena</surname> <given-names>M-B</given-names>
</name>
<name>
<surname>Jean-Hugues</surname> <given-names>G</given-names>
</name>
<name>
<surname>Belen</surname> <given-names>P-OA</given-names>
</name>
<name>
<surname>Christophe</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Beyond current treatment of Fanconi Anemia: What do advances in cell and gene-based approaches offer</article-title>? <source>Blood Rev</source>. (<year>2023</year>) <volume>60</volume>:<fpage>101094</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.blre.2023.101094</pub-id>
</citation>
</ref>
<ref id="B190">
<label>190</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verhoeyen</surname> <given-names>E</given-names>
</name>
<name>
<surname>Jose Roman-Rodriguez</surname> <given-names>F</given-names>
</name>
<name>
<surname>Cosset</surname> <given-names>F-L</given-names>
</name>
<name>
<surname>Levy</surname> <given-names>C</given-names>
</name>
<name>
<surname>Rio</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Gene therapy in Fanconi anemia: a matter of time, safety and gene transfer tool efficiency</article-title>. <source>Curr Gene Ther</source>. (<year>2016</year>) <volume>16</volume>:<fpage>297</fpage>&#x2013;<lpage>308</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/1566523217666170109114309</pub-id>
</citation>
</ref>
<ref id="B191">
<label>191</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diez</surname> <given-names>B</given-names>
</name>
<name>
<surname>Genovese</surname> <given-names>P</given-names>
</name>
<name>
<surname>Roman-Rodriguez</surname> <given-names>FJ</given-names>
</name>
<name>
<surname>Alvarez</surname> <given-names>L</given-names>
</name>
<name>
<surname>Schiroli</surname> <given-names>G</given-names>
</name>
<name>
<surname>Ugalde</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Therapeutic gene editing in CD 34+ hematopoietic progenitors from Fanconi anemia patients</article-title>. <source>EMBO Mol Med</source>. (<year>2017</year>) <volume>9</volume>:<page-range>1574&#x2013;88</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.15252/emmm.201707540</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>
